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ABSTRACT 
DNA methylation is a key event regulating gene expression. DNA methylation 
analysis plays a pivotal role in unlocking association of epigenetic events with cancer. 
However, simultaneous evaluation of the methylation status of multiple genes is still a 
technical challenge. Microarray is a promising approach for high-throughput analysis of 
the methylation status at numerous CpG sites within multiple genes of interest. In this 
dissertation study, we conducted a systematic study to examine the use of microarray 
methods for methylation analysis.  
First, a robust universal microarray was established with more flexible in design 
and content, and potential cost saving over commercial arrays. In order to produce high 
quality microarray data, we optimized the attachment chemistry for the modified 
oligonucleotides, searched for the good combination of fluorescent dyes, and 
 v
hybridization conditions. To improve the specificity of the microarray, we conducted a 
study to experimentally search for a set of highly discriminative tag Sequences. 
Second, SBE-TAGs microarray was successfully adapted from the SNP 
detection for methylation analysis of multiple genes. SBE-TAGs microarray performed 
quite well in multiplex methylation analysis of cell lines if a standard calibration curve 
method was used. 10 CpG sites of 9 tumor suppressor genes (MGMT, GATA4, HLTF, 
SOCS1, p16, RASSF2, CHFR, TPEF, and Reprimo) were selected for this study.  
Third, a novel method called CHZMA (Competing-Hybridization- 
Zipcode-MicroArray) was developed for methylation analysis of tumor tissue samples, 
which is based on two steps of hybridization to achieve the specific detection of 
methylation on microarray. On the basis of analysis of seven genes (MGMT, GATA4, 
HLTF, SOCS1, RASSF2, ER, 3-OST-2), we found that the CHZMA assay can robustly 
detect methylation of multiple genes in the samples containing as low as 10% of 
methylated DNA. With the strict control group test and statistical analysis, CHZMA can 
be a good high-throughput method in place of MSP for methylation analysis of tumor 
tissue samples. 
These studies provide reliable and robust tools for methylation analysis, and 
could be used for cancer prognosis and diagnosis in the future.  
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CHAPTER I 
CURRENT DNA METHYLATION ANALYSIS METHODOLOGY 
 
1.1 Introduction 
1.1.1 DNA Methylation: the Major Form of Epigenetic Change in Genome 
It is now clear that genetic and epigenetic are the two forms of information 
included in genome. Genetic information provides the blueprint to manufacture all of the 
proteins, while epigenetic information provides the instruction to use these proteins 
(Robertson 2001). In the mammalian cell, methylation is a major form of epigenetic 
change, which is modified by DNA methyltransferases (DNMTs) adding a methyl group 
on the 5-position of cytosine within the CpG dinucleotide site (Doerfler 1983). 
Approximately, 70-80% of CpG sites in the mammalian genome contain methylated 
cytosines (Antequera and Bird 1993; Bird 1995). Methylated cytosines are widely spread 
throughout the genome, predominantly in repetitive genomic regions, including satellite 
DNA and parasitic elements (Yoder et al.1997). Unmethylated CpG sites are primarily 
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confined to DNA regions with high relative densities of CpG, called CpG islands, 
ranging from 0.5 to 5 kb and occurring on average every 100 kb (Bird 1986; 
Gardiner-Garden and Formmer 1987). Recently, it is estimated at least 29, 000 CpG 
islands in the human genome (Lander et al. 2001; Venter et al. 2001), are distributed in a 
non-random pattern, particularly in the promoters and the first exon regions of protein 
coding genes (Bird 1986).  
DNA methylation is a crucial epigenetic alteration, involved in embryonic 
development, transcription, chromatin structure, X chromosome inactivation, genomic 
imprinting and chromosome stability. In the normal cell, most CpG islands remaining 
unmethylated are associated with transcriptionally active genes, and some CpG islands 
were found normally methylated in imprinted genes (Li et al. 1993; Paulsen and 
Ferguson-Smith 2001), X chromosome inactivation genes (Panning and Jaenisch 1998), 
and parasitic DNA suppression genes (Walsh et al. 1998). Whereas DNA methylation is a 
crucial mechanism to regulate the genetic information, it also adds an additional burden, 
such as abnormal methylation was found in human carcinogenesis.  
1.1.2 DNA Methylation and Cancer 
As the two major forms of methylation, genome-wide hypomethylation and 
region-specific hypermethylation have been broadly found in carcinogenesis. In human 
carcinogenesis, the hypermethylation in promoters will repress transcription via the 
inhibiting the binding of specific transcription factors directly, or via local changes in 
histone modification and chromatin structure by methyl-CpG-binding proteins indirectly 
(Robertson 2005). In contrast, the biological significance of genome-wide 
hypomethylation in the repetitive regions is less understood. However, global 
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measurements of DNA hypomethylation remain a valuable tool for understanding the 
molecular pathology of human cancer, and for monitoring therapeutic responses to 
potential compounds in human clinical trials. It is clear that DNA hypomethylation can 
foster chromosome instability (Ehrlich 2002; Eden et al. 2003), increase the mobility of 
transposable elements (Walsh et al. 1998), and induce tumorigenesis in different mouse 
models (Eden et al. 2003; Gaudet et al. 2003; Yamada et al. 2005; Jones and Baylin 2007). 
In addition, the correlation between hypomethylation and increased gene expression was 
reported for many oncogenes (Feinberg and Vogelstein 1983; Hanada et al. 1993).  
In cancer, promoter hypermethylation is associated with gene silencing, and 
together with point mutations and deletions, serves as one of the most common 
mechanisms for the loss of function of tumor suppressor genes (Baylin et al. 1998; 
Costello and Plass 2001; Jones and Baylin 2002; Robertson 2001; Robertson2005). 
Because of the importance of hypermethylation in carcinogenesis, a growing number of 
studies have provided fundamental insights into cancer development. In virtually every 
type of human neoplasm, promoter methylation is found to be associated with 
inappropriate transcriptional silencing of genes (Costello et al. 2000; Toyooka et al. 2001; 
Rashid et al. 2001; Martens et al. 2005; Sato et al. 2005; Kusano et al. 2006). As DNA 
methylation is more readily reversible than genetic events, DNA hypermethylation in 
promoter is emerging as a potential diagnostic and prognostic tool (Karpf and Jones 
2002). 
1.1.3 DNA Methylation Analysis 
DNA methylation research can be approached from a wide range of techniques. 
Each technique has its own peculiarities to offer a different perspective for occurrence  
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and localization of methylation in the genome. In this chapter, a summary of the most 
commonly used techniques will be provided for methylation research, in particularly for 
hypermethylation analysis. A general outline of the principles, advantages, and 
disadvantages of these techniques will be discussed in each section. The current methods 
can be broadly classed into two major approaches: global methylation analysis 
(genome-wide); and site-specific methylation status determination (Oakeley 1999; Fraga 
and Esteller 2002; Laird 2003). In the following, all of the methods will be grouped into 
these two categories (Fig. 1). In global methylation analysis, high-performance separation 
(HPLC and HPCE), enzymatic reaction, chemical reaction, and immunology-based 
methods will be discussed. In site-specific methylation analysis, the methods are divided 
into two subcategories, bisulfite and non-bisulfite treatment. For the non-bisulfite 
methods, we focused on the application of methylation-sensitive and 
methylation-insensitive restriction endonucleases. For the bisulfite treatment methods, a 
series of methods including sequencing, methylation-specific PCR (MSP), quantitative 
MSP (QMSP), single base extension, ligation, fragment analysis, and microarray et al., 
will be discussed. 
1.2 Global Methylation Analysis 
1.2.1 Reverse-Phase HPLC (RP-HPLC)  
Global genomic DNA methylation status can be determined by reverse-phase HPLC 
using chemical or enzymatic hydrolysis of DNA. In the chemical hydrolysis, DNA is 
incubated in formic acid (Eick et al. 1983) or hydrofluoric acid (Catania et al. 1987). 
After the hydrolysis, liberated cytosine, thymine, guanine, adenine, and 5-methylcytosine 
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 Fig. 1 The methods of DNA methylation analysis. The existing methylation analysis 
methods are assorted into global and site-specific analysis. The site-specific analysis 
includes two categories: non-bisulfite and bisulfite analysis. MSP: methylation-specific 
PCR; SBE: single base extension.  
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are subsequently separated and determined by reverse-phase HPLC. Since the 
deamination of cytosine and 5-methylcytosine occurs during the hydrolysis procedure 
using formic acid, quantitation of 5-methylcytosine in DNA is not as accurate as 
hydrofluoric acid is used in hydrolysis.  
As an alternative, enzymatic hydrolysis presents more power in quantitative 
methylation analysis. The DNA sample is the hydrolyzed to produce 
2’-deoxymononucleosides, using DNase I, Nuclease P1, or snake venom 
phosphodiesterase, followed by alkaline phosphatase treatment (Kuo et al. 1980; Ehrlich 
1982; Gomes and Chang 1983). The liberated 2’-deoxymononucleosides are separated 
and detected by standard HPLC-UV system, which can detect 2–10% of the 
5-methylcytosine (m5C) (Kuo et al. 1980; Wagner and Capesius 1981; Gama-Sosa et al. 
1983). HPLC operating with fluorescence detection can provide a 10-fold higher 
sensitivity, but has drawbacks with tedious labeling procedures (Sonoki et al. 1998; Wirtz 
et al. 2004). 
Recently, with the utilizing of HPLC-MS system, the sensitivity of methylation 
detection has been greatly improved. Babinger and co-workers used RP-HPLC combined 
with electrospray mass spectrometry (ESI-MS) to analyze Volvox DNA. As little as 1.1% 
of 5-methylcytosine was detected in total deoxycytidine residues of genome (Babinger et 
al. 2001). Friso also detected about 1.7-1.9% of 5-methylcytosine in total deoxycytidine 
with <1μg DNA sample, using HPLC-ESI system (Friso et al. 2002). However, RNA 
contamination of the DNA sample could cause the quantification to fail, as ESI-MS was 
incapable of distinguishing 5-methyl-2’-deoxycytidine from 5-methyl-2’-cytidine (Havlis 
and Trgbusek 2002). Alternatively, Sony et al. have developed a highly specific and 
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sensitive assay with tandem mass spectrometry (Song et al. 2005). With this 
HPLC-ESI-MS/MS system, methylation levels ranging from 0.05 to 10% can be detected 
in 4 ng of DNA. This detection sensitivity should permit the use of this method for 
applications having limiting amounts of DNA in clinical samples.  
1.2.2 Thin-Layer Chromatography (TLC) 
The TLC was initially reported for separation and determination of 
5-methyldeoxycytosine (m5dC) in 1981 (Wagner and Capesius 1981). In this assay, the 
restriction enzyme MspI cuts the target site CCGG regardless of whether cytosine is 
methylated or not. Bestor and Schmitt groups labeled the internal cytosine with [32P]ATP 
and polynucleotide kinase, then hydrolyzed the nucleotides with nuclease P1 to 
individual nucleotides, which is separated on 1-D or 2-D cellulose thin-layer 
chromatography plates (Bestor et al. 1984; Schmitt et al. 1997). In Leonard and Gowher 
studies, the nucleotides were digested to individual nucleotides, which are separated by 
RP-HPLC to isolate both m5dC and dC. Then, the individual m5dC and dC were labeled 
with [32P]ATP and polynucleotide kinase. Finally, the 1-D or 2-D TLC was used to 
identify the methylation status (Leonard et al. 1993; Gowher et al. 2000). This sensitive 
assay could detect the presence of m5C in genomic DNA at the level of 1 in 1000-2000 
cytosine residues (Leonard et al. 1993). One of the shortcomings of this method is that 
digesting the nucleotides to produce individual m5dC and dC prior to the labeling makes 
the dC much easier to label than m5dC. This will reduce the detection limit of m5dC in 
genomic sample. In addition, noisy signals from A, G, and T were observed on the TLC 
plates (Oakeley 1999).  
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1.2.3 High Performance Capillary Electrophoresis (HPCE) 
Two major modifications of capillary electrophoresis: micellar-electrokinetic 
capillary chromatography and capillary zone electrophoresis, are frequently used in 
global methylation analysis. Fraga et al. has reported a new open-tube capillary 
electrophoresis system to separate the acidic/enzymatic hydrolyzed genomic DNA for 
methylation analysis. The dC and m5dC were successfully separated in SDS 
micellar-electrokinetic system with UV detection (Fraga et al. 2000). In contrast to HPLC, 
HPCE does not need specific running buffer, and is faster than HPLC with 10min/sample. 
The limitation of detection is one m5dC in 200 dC, using a 1μg DNA sample. Sandoval 
Guerrero et al. optimized this system to more efficient peaks, a flatter base line, and 
shorter analysis time with employing a fused-silica capillary (75 mm inner diameter) of 
44.5 cm effective length, 20 mM carbonate buffer (pH 9.6) plus 80 mM sodium dodecyl 
sulfate (Sandoval Guerrero et al. 2005). To overcome the limitation of the UV detection 
at 280 nm, Schmitz’s group developed a laser-induced fluorescence detection system to 
improve the sensitivity (Lyko et al. 2004; Wirtz et al. 2004). In the assay, the hydrolyzed 
mono-nucleotides, including dC and m5dC, were modified with fluorescent dye (Bodipy 
FLEDA), then separated in micellar-electrokinetic chromatography and detected with the 
laser-induced fluorescence system. After optimization, the method can determine the 
methylation level in 100-ng DNA samples (10 folds better than UV) with a standard 
deviation of less than 5%, suitable for clinical sample testing.  
Recently, a new capillary zone electrophoresis method applying short-end 
injection technique was reported (Sotgia et al. 2008). By injecting the sample at the 
capillary end, closest to the detector window, the migration distance of analytes is 
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significantly reduced to10.2 cm. Thus, dC and m5dC after acid hydrolysis were separated 
with a good resolution in less than 1.5 min, which is much shorter than normal injection 
with 6-10min. The lowest amount of DNA required to evaluate methylation is about 0.5 
μg.  
1.2.4 Enzymatic Method 
In vivo, SssI methyltransferase (CpG methylase) catalyses the transfer of a 
methyl group from S-adenosyl-L-methionine (SAM) to C5 of cytosine within CpG 
dinucleotide sequences in genomic DNA shortly after DNA replication (Baylin 1997). 
Under this mechanism, SssI methyltransferase based enzymatic methods were developed 
for methylaiton analysis (Adams et al. 1991; Balaghi et al. 1993; Wu et al. 1993; 
Belinsky et al. 1995; Schmitt et al. 1997). In this assay, [Methyl-3H]SAM is used as a 
substrate to incorporate into all of the unmethylated cytosines in CpG sites of genomic 
DNA under the catalyses of SssI methyltransferase. After that, the labeled DNA is 
collected on filter paper, washed, and counted in a scintillation counter. The amount of 
incorporated radioactive Tritium is proportional to the unmethylated level of the DNA 
sample. Due to the crude or semipurified preparations of SssI methyltransferase, RNA 
and protein remaining in genomic DNA may possibly be labeled with [Methyl-3H]SAM 
in the presence of other methyltransferases to yield artificial results. Furthermore, the 
nonspecific absorption of radioactivity in the precipitates can also yield error results 
(Chiang et al. 1996). Fiala et al. developed a modified SssI methyltransferase assay for 
hypomethylation analysis in tissue samples, using HPLC with radioflow detection after 
enzymatic hydrolysis, enhancing specificity and reliability (Fiala et al. 1998). The 
problem with the SssI methyltransferase assay is the handling and disposal of Tritium. 
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1.2.5 Chemical Method 
Oakeley et al. developed a method to label any m5dC in genomic sequence with 
sodium bisulfite and chloracetaldehyde reaction (Oakeley et al. 1999). First, the genomic 
DNA was subjected into bisulfite treatment, which coverted all of dC into dU, while 
having no effect on m5dC (Frommer et al. 1992). Second, using sulphuric acid, bisulfite 
treated DNA was depurinated to eliminate 99% of dA, which was precipitated with silver 
nitrate. The supernatant was incubated with chloracetaldehyde to form ethenocytosine 
(derivative of m5dC), and residual ethenoadenine (derivative of dA). Both of these two 
derivatives are intensely fluorescent and with two different major peaks. Only dA, dC, 
and m5dC can react with chloracetaldehyde. Hence, the bisulfite conversion and dA 
removal are critical to the assay. After the fluorescence scanning, the methylation signal 
was determined by removing the contamination of ethenoadenine. As the 
chloracetaldehyde is quite toxic, special care must be taken in the labeling and 
detoxification.  
Recently, Okamoto group reported a m5dC-selective reaction with potassium 
osmate, functional bipyridine, and potassium hexacyanoferrate (III) (Okamoto et al. 2006; 
Tanaka et al. 2007 a, b). This osmate reaction distinguished m5dC and dC with high 
selectivity. All of the study of this new method is focused in site-specific methylation 
detection with a hybridization probe. But this reaction has great potential for global 
methylation analysis, if combined with other techniques. Chemical based analysis, as a 
good alternative mean, can detect any m5dC in the genomic DNA. 
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1.2.6 Immunological Method 
Using monoclonal antibodies directed against m5C is another approach for 
global DNA methylation analysis. Podestà et al. described the preparation and basic 
properties of monoclonal IgG1 (Podestà et al. 1993), whose specificity was validated by 
using methylated and unmethylated oligonucleotides (Oakeley et al.1997) In this assay, a 
DNA sample is immobilized on the DEAE membrane, then incubated in monoclonal 
IgG1, followed by incubating in the secondary antibody of FITC-labeled goat anti-mouse 
IgG for fluorescence scanning (Oakeley et al.1997; Zluvova et al. 2001). The methylation 
level is proportional to the intensity of the fluorescent signal on the membrane. The 
amount of DNA loaded on membrane is measured by ethidium bromide fluorescence 
staining after the fluorescent scanning.  
The outstanding feature of immunology assay is to visualize the chromosomal 
methylation patterns by fluorescence microscopy on a cell-by-cell basis. The DNA in 
chromosomes can be labeled only when m5dC is not base-paired. In the early research, 
UV light, alkali, or heat treatment was used for long time denaturation of chromosome 
(Miller et al. 1974; Barbin et al. 1994; Montpellier et al. 1994; Rougier et al. 1998). After 
the denaturation, the mono-antibodies combined with fluorescence dye were incorporated 
into chromosome. Due to the disruption of chromosome structure in the denaturation, 
gentle conditions were used in denaturation with a short UV light exposure (three hours) 
at a low temperature (4oC) (Bensaada et al. 1998). This method can be used to determine 
the methylated status of chromosomes, and to map not only the structural (banding) but 
also the functional (methylation status) properties of the different chromosome domains 
in cells. 
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1.3 Restriction Analysis for Site-Specific Methylation Detection 
Methylation-sensitive digestion combined with insensitive restriction 
endonucleases provide a simple tool for methylation analysis of large quantities DNA. As 
the most common isoschizomers, HpaII and MspI are used to cleave the DNA at CCGG 
target, where HpaII is not able to cut the sequence when m5dC is present in the CpG site 
(Cedar et al. 1979; Singer et al. 1979; Bird 1980). The DNA samples are digested by 
HpaII and MspI, respectively. Then, the different size of the digests will be revealed on 
Southern blot by hybridizing with radio isotope labeled probe. If the HpaII and MspI 
digests have the same size hybridized bands, the target site covered by probe is 
unmethylated. In the contrast, if the hybridized bands of HpaII are bigger than MspI, the 
target site is methylated. To improve the sensitivity, PCR was used to amplify the digests 
(Singer-Sam et al. 1990). The PCR amplification region must contain single CCGG or 
more. If the CCGG is methylated, only DNA digested with HpaII can be amplified, and 
no PCR amplification is from MspI digests. If the CCGG is unmethylated, both of HpaII 
and MspI digests can not amplify with the cleaved templates. For PCR detection, less 
than 10ng DNA is required for digestion, whereas 10μg is required for Southern blot 
detection. Furthermore, 1 m5dC in 1000 dC is able to be detected (Kutueva et al. 1996). 
Although this method is straightforward, some problems arise from the limitation of 
restriction sites, false-positives caused by partial digest, and the high molecular weight 
DNA requirement.  
Recently, Methylation-specific multiplex ligation-dependent probe amplification 
(MS-MLPA) was reported to detect 40 sequences simultaneously, using only 20ng of 
DNA (Nygren et al. 2005). In the assay, the methylated and unmethylated DNA samples 
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were denatured and hybridized with one pair of ligation probes with universal sequence, 
followed by simultaneously ligated and digested with ligase and methylation sensitive 
endonucleases. The ligated unmethylated sequence was cleaved by methylation sensitive 
endonucleases, and could not be amplified by universal primers. The ligated methylated 
sequence remained intact as a template for PCR amplification. The PCR products with 
different sizes were measured by fragment analysis.  
Restriction landmark genomic scanning (RLGS) is another restriction enzyme 
based method, which can evaluate over 2000 loci simultaneously with two-dimensional 
gel electrophoresis of digested genomic DNA (Hatada et al. 1991). In the methylation 
analysis, DNA is digested with methylation-sensitive enzyme, like NotI (GCGGCCGC) 
or AscI (GGCGCGCC), and directly labeled with a radioactive isotope. Methylated sites 
are not digested and are therefore not labeled, thus they do not contribute to the 
two-dimensional pattern of RLGS fragments. The DNA samples require the high-quality, 
high-molecular-weight to prevent nonspecific labeling of degraded fragments. After the 
first restriction digest with methylation-sensitive enzyme, the DNA is subjected to the 
second restriction to produce short strands for the first-dimension electrophoresis with 
0.8% agarose gel. Following that, DNA in agarose is restriction digested at 3rd time to 
produce shorter strands for second-dimension electrophoresis in a large 5% acrylamide 
gel. Finally, the digested sites from the unmethylation sequence display with 
corresponding spots with the autoradiography. With the control profiles from normal 
group, they can determine the absent spot, which results from the failure of 
methylation-sensitive digest and represents the methylation site in the sample (Shibata et 
al. 1995; Akama et al. 1997; Costello et al. 2000; Matsuyama et al. 2003). Although  
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RLGS is highly reproducible, the assignment of specific genomic sequences to RLGS 
spots is still a challenge. Plass and co-workers set up the standard data system, called 
Master profile, for each locus assignment (Smiraglia and Plass 2002; Rusha and Plass 
2002). With the completion of the human and mouse genome sequences, a virtual RLGS 
profile based on the bioinformatics approach became available for RLGS fragment 
identification. In the virtual RLGS profile each restriction fragment's migration in both 
dimensions could be predicted (Rouillard et al. 2001; Smiraglia et al. 2007). As much, 
RLGS has become a versatile tool in hypomethylation and hypermethylation analysis for 
normal tissues, primary tumors, and cancer cell lines in various organisms.  
1.4 Bisulfite-Based Methods for Site-Specific Methylation Detection 
1.4.1 Bisulfite Conversion 
The analysis of DNA methylation was revolutionized by sodium bisulfite 
conversion, which permits the indentification of any CpG sites in the genome, rather than 
the specific sequences targeted by restriction endonucleases. The different conversion 
rates of cytosine and 5-methylcytosine deaminated by sodium bisulfite to yield uracil and 
thymine were described in 1970s (Hayatsu et al. 1970; Shapiro et al. 1970; Hayatsu and 
Shiragami 1979). This converstion did not get much attention until Frommer et al. used it 
to distinguish the dC and m5dC. The breakthrough in this area is that bisulfite converts all 
of dCs to uracils whereas the m5dC residues remain intact. Then, the treated DNA is 
subjected to PCR amplification to yield fragments wherein Ts replace Us (former Cs), 
and Cs replace the methylated Cs (Frommer et al. 1992). Based on this conversion, DNA 
methylation research can be approached from a wide range of techniques, including 
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sequencing, methylation-specific PCR, combined bisulfite restriction assays, microarray, 
and others (Fig. 2).  
In the bisulfite treatment, the incomplete conversion of dCs will cause 
false-positive results. To prevent the non-converted dCs, special attention should be paid 
for DNA denaturation, desulfonation, bisulfite sodium concentration, and reaction 
conditions, whereas, 84-96% of the DNA is degraded under this condition (Grunau et al. 
2001). More significant losses are found during the subsequent reaction and purification 
for short strand DNA, thus more than 99% of DNA can be degraded (Munson et al. 2007; 
Tanaka and Okamoto 2007).  
As the bisulfite conversion is susceptible to processing errors, several attempts 
have been made to simplify the treatment. Raizis et al. reported that using high 
concentration (5M) of sodium bisulfite can reduce the degradation with 4h incubation 
(Raizis et al. 1995). Olek et al. performed the bisulfite treatment and subsequent PCR 
steps with low melting point agarose beads, in which the denatured DNA will be kept in 
single strand form to avoid strand annealing (Olek et al. 1996). The single strand DNA 
improves the reaction efficiency, and reduces the reaction time to 4h. On the other hand, 
the subsequent reaction and purification of bisulfite converted DNA within agarose beads 
will be gentle to reduce the DNA strand cleavage. With these two modifications, 500 pg 
of starting DNA can provide reliable PCR products. Many research works focused on 
clinical specimens rely on this agarose beads based method to improve the recovery of 
bisulfite treated DNA, in particularly in tiny tissue and serum specimens, which often 
provide less than 50ng DNA (Kitazawa et al. 2000; Kim et al. 2005; Peng et al. 2006). To 
reduce the matrix binding loss in the desulfonation and purification, centrifugal filtration 
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 Fig. 2 Bisulfite conversion. (A) In the bisulfite treatment, only normal cytosine is 
converted to uracil, and 5-methylcytosine is intact. (B) The treated DNA is amplified in 
PCR to generate fragments wherein Ts replace Us (former Cs), and Cs replace the 
methylated Cs. These sequence variation can be analyzed using conventional SNP or 
mutation analysis methods. 
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was used to provide a simplified, high-recovery procedure that lends itself to increased 
throughput and can be applied to 300 pg starting DNA (Boyd and Zon 2004). Recently, 
the molecular diagnostic researchers target the tumor-derived short strand DNA in 
samples such as blood (Cottrell and Laird 2003; Lofton-Day et al. 2008), urine (Westra et 
al. 2006; Yu et al. 2007), sputum or saliva (Konno et al. 2004) and stool (Chen et al. 2005; 
Zhang et al. 2007; Wang and Tang 2008). However, the degradation of the tiny DNA in 
bisulfite treatment is still a big challenge to improve the sensitivity and specificity. 
1.4.2 Sequencing 
Bisulfite sequencing genomic DNA is the most common method in methylation 
analysis. The PCR primers are designed without CpG sites contained in their sequence to 
ensure unbiased amplification of both methylated or unmethylated DNA. After the PCR 
amplifies, the PCR product can be subjected for the direct sequencing, or subcloning 
followed by sequencing the subclones (Frommer et al. 1992). The direct sequencing is 
fast, simple, and may better reveal the overall methylation status of the DNA sample. The 
human epigenome project in Europe used direct sequencing of bisulfite PCR products 
(Rakyan et al. 2004; Eckhardt et al. 2006). In this method, the methylation status of any 
given CpG site is the average of all amplicons generated during PCR. Sequencing the 
subcloned PCR products is time consuming, but can deliver the methylation patterns of 
individual molecules. This provides a better understanding of complex pattern of 
methylation such as monoallelic methylation and incomplete allele methylation. Because 
of the DNA methylation patterns with the ability to reflect different functions of the DNA 
methylation system (Colot and Rossignol 1999), sequencing of subclones has been used 
to study cancer related methylated genes such as APC (Esteller et al. 2000), Rb (Stirzaker 
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et al. 1997), TMS (Levine et al. 2003), and RASSF1A (Peters et al. 2007).  
As alternative sequencing to conventional chain termination sequencing (Sanger 
et al. 1977), pyrosequencing holds great promise for both confirmatory sequencing and 
de novo sequencing (Ronaghi et al. 1996; Ronaghi et al. 1998). Pyrosequencing is a 
sequencing-by-synthesis technique based on the detection of released pyrophosphate (PPi) 
during DNA synthesis. With ATP sulfurylase, the released PPi is subsequently converted 
to ATP, which provides the energy to luciferase to oxidize luciferin and generate light. 
The intensity of the light is proportional to the number of incorporated nucleotides and 
the sequence is determined by added nucleotide in the cycling reaction.  
However, this technique has not been used for genome sequencing due to the 
short read length about 1-300 nucleotides (Mashayekhi and Ronaghi 2007). The 
interesting thing is that this limitation makes pyrosequencing suitable for bisulfite treated 
DNA with short strands (Uhlmann et al. 2002). Moreover, since pyrosequencing works 
better on small PCR products (100-150 bp), it provides good resolution for clinical or 
archival sample with partial degraded DNA, which is a big problem with other techniques 
(Colella et al. 2003; Tost et al. 2003; Shaw et al. 2006). Recently, a novel parallel 
pyrosequencing in microfabricated high-density picolitre reactors was developed by 454 
sequencing (Margulies et al. 2005). With this new platform, around 300,000 DNA 
templates with 100 bp length can be simultaneously sequenced in 5.5 h with an accuracy 
of 99.6%. This technology provides high-throughput and ultradeep methylation analysis 
for multiple tumor types, and multiple genes. Taylor et al. described the methylation 
pattern analysis of 294,631 DNA fragments with an average read length of 131bp from 
25 gene-related CpG rich regions in more than 40 primary cells (Taylor et al. 2007). 
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Korshunova et al. reported the methylation patterns of more than 700,000 DNA 
fragments derived from breast tissues and circulating DNA in more than 50 individuals 
(Korshunova et al. 2008).  
1.4.3 Methylation-Specific PCR 
Methylation-specific PCR (MSP) is the most common used method for 
methylation analysis, because of its high sensitivity and simplicity (Herman et al. 1996). 
The differences of methylated and unmethylated sequences derived from bisulfite 
conversion are the basis of MSP, in particularly in CpG islands. MSP reveals the 
methylation status of the CpG sites within the two short sequences targeted by MSP 
primers. Hence, the primer design is crucial to the discrimination power of MSP, where 
methylation-specific and unmethylated DNA-specific primers cover the same CpG sites 
and yield different PCR products, respectively.  
To avoid the labor-intensive gel electrophoresis after the MSP, Lo et al. and Eads 
et al. adopted the fluorescence-based real-time PCR (TaqMan) for high-throughput 
quantitative MSP (QMSP), which was highly sensitive and can detect one methylated 
allele in 10,000 copies of unmethylated alleles (Lo et al. 1999; Eads et al. 2000). In this 
QMSP, the methylation level was calculated by dividing the methylated signal with the 
sum of methylated signal and unmethylated signal. Sidransky and co-workers simplified 
this QMSP using the unique internal reference gene such as MyOD1 (Jerónimo et al. 
2001), and ACTB (Harden et al. 2003; Hoque et al. 2006), which do not have CpG sites 
in their sequence. The ratio of signal from methylated amplification to internal reference 
was used to measure the relative methylation level of the target gene. In this simplified 
QMSP system, only the primers for methylated allele were contained, but no primers for 
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unmethylated allele. 
However, MSP is prone to false-positive because of the low discrimination of 
primers, especially in incompletely converted sequences in the bisulfite- treated DNA 
(Aggerholm et al. 2000; Rand et al. 2002). To avoid the false-positive results caused by 
non-specific amplification, sensitive melting analysis after real time (SMART)-MSP was 
reported for sensitive DNA methylation detection based on probe-free real-time PCR 
(Kristensen et al. 2008). In this assay, the false-positive results due to incomplete bisulfite 
conversion or false priming can be identified by high-resolution melting.  
1.4.4 Single Base Extension  
Gonzalgo et al. first used the single base extension (SBE) for quantitative 
methylation analysis of individual CpG sites using bisulfite-PCR products (Gonzalgo and 
Jones 1997). SBE is then performed with oligonucleotides designed to hybridize 
immediately upstream of the CpG site being interrogated. The product can be detected by 
the adding radioactive ddC/ddT (ddG/ddA) on polyacrylamide gels. Several new 
detection methods have been developed to improve the performance. Based on the 
different masses and hydrophobicities of incorporated ddNTP, the methylated and 
unmethylated CpG sites can be discriminated and quantified by ion pair reverse phase (IP 
RP) HPLC (El-Maarri et al. 2002). Using this method, several CpG sites contained in 
different SBE products can be measured simultaneously with high reproducibility. Dye 
labeled ddNTPs are reported for the SBE reaction, followed by capillary electrophoresis 
with ABI Prism® 3100 Genetic Analyzer (Applied Biosystems, CA) (Hong et al. 2005; 
Kaminsky et al. 2005). In this method, the first discrimination is to use 
methylated-specific and unmethylated- specific primers with different length but 
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covering the same CpG sites to anneal the template. The second discrimination is the 
SBE reaction with different dye labeled ddNTPs. After the electrophoresis, the peaks of 
methylated and unmethylated primers with extension will show at different positions.  
Since MALDI-TOF mass spectrometry combined with primer extension has 
been shown to be a powerful tool in SNP analysis, Schatz et al. described the 
combination of MALDI-TOF and primer extension for methylation analysis (Schatz et al. 
2003). In the assay, the extension with α-S-ddNTPs results in a product with a 
phosphorothioate backbone. After SBE, the part of the primer containing regular 
phosphate bonds is digested off with 5'-phosphodiesterase, while the first 
phosphorothioate group from the 5'-end inhibits the digestion of the product. Finally the 
phosphorothioate functions are measured by MALDI-TOF. 
In chapter IV, we will present our study with SBE based microarray for 
high-throughput analysis of multiple genes, and multiple CpG sites.  
1.4.5 Ligation  
Recently, with bisulfite treatment, two ligation-based microarray methods were 
developed for methylation analysis (Bibikova et al. 2006; Cheng et al. 2006). In the first 
method, Barany and coworkers developed a PCR/LDR method for methylation analysis 
(Cheng et al. 2006). Briefly, it first utilizes multiplexed PCR to amplify multiple target 
DNA sequences, followed by ligation chain reactions, where methylated-specific and 
unmethylated-specific probes modified with two different dyes (Cy3/Cy5). The ligation 
products are then analyzed using microarray to determine the methylation status at each 
target CpG site via the different fluorescence signals.  
In the second method, Fan and his team from Illumina apply a genotyping 
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system to methylation analysis (Bibikova et al. 2006). Fan’s approach first utilizes 
extension and ligation to produce both methylated and unmethylated alleles, followed by 
multiplexed PCR with fluoresce labeled universal primers to amplify the sequences 
containing the target CpG site. The methylation status at each CpG site is analyzed using 
microarray. In Fan’s method, in order to improve the specificity, a gap (1-20bp) was 
designed between the ligation probes. This gap can be filled by extension of DNA 
polymerase. Ligation-based microarray improves specificity, allowing for methylation 
analysis of cancer cell lines or tumor tissues that contain high abundance of tumor cells. 
However, it is still not a robust method for methylation analysis of tumor tissues that 
contain a minority of tumor cells. This is because the specificity of annealing a probe to a 
given sequence varies greatly from one sequence to another (Dahl and Guldberg 2007). 
1.4.6 Fragment Analysis 
Fragment analysis as the most straightforward method was developed by Boyd 
et al. from ABI (Applied Biosystems, CA) (Boyd et al. 2006). In this assay, amplicons 
with different size bisulfite-converted DNA are analyzed immediately after multiplex 
PCR with fluorescence labeled primers. In gel-capillary electrophoresis, methylated 
amplicon migrates faster than the unmethylated amplicon. The PCR products of 
methylated allele and unmethylated allele can be separated due to the accumulation of 
several cytosines or thymines in the amplicons, respectively. Furthermore, this assay can 
be used for quantitative analysis the overall methylation level in the selected area. To 
improve the resolution of methylated and unmethylated peaks due to presence of only a 
few CpG sites, the modified dCTP is incorporated in the PCR (Boyd et al. 2007). This 
modified dCTP incorporated in PCR products allows for the detection of single C/T 
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difference derived from single CpG after bisulfite conversion. The only problem with this 
method is the methylation status can not be assigned to every CpG site in PCR product 
with multiple CpG sites. But this direct analysis of bisulfite-converted PCR products 
without any additional sample processing provides a robust tool for high-throughput 
quantitative methylation analysis, in particular for the hypermethylation analysis in CpG 
islands.  
1.5 Conclusion 
DNA methylation is a crucial epigenetic change and is involved in regulating 
many cellular processes, particularly in relation with gene silencing in disease. Consistent 
with these important roles, a growing number of methylation detection techniques have 
been developed to provide fundamental insights into DNA methylation. In this short 
review, some representative techniques have been introduced to address global and 
site-specific methylation analysis. Each technique has its own peculiarities to provide a 
unique approach for a specific problem. In some cases, DNA methylation analysis will 
combine several methods together to get reliable results. Microarray as an alternative has 
been widely used in methylaiton detection. Since the microarray application in 
methylation is the major study of this project, the different platforms of microarray 
related to methylation analysis will be described in detail in chapter II. 
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CHAPTER II 
HIGH-THROUGHPUT DNA METHYLATION PROFILING USING 
MICROARRAY 
2.1 Introduction  
DNA microarrays are miniature arrays of DNA fragments attached to solid 
supports, enabling a simultaneous analysis of a large amount of genetic information. Two 
major forms of microarray were developed by fixing a target DNA fragment or detecting 
oligonucleotide probes. The first form of microarray was evolved from Southern blotting, 
whereby oligonucleotide probes are attached to a substrate and then hybridized with the 
target DNA fragments (Southern et al. 1992). In the second form, Drmanac and 
co-workers immobilized target DNA on the solid support first, then hybridized with 
oligonucleotide probes (Drmanac et al. 1989; Drmanac et al. 1993). At the beginning, the 
microarray was used for quantitative monitoring of gene expression, where thousands of 
genes were evaluated simultaneously (Schena et al. 1995). Then, different platforms of 
microarray were developed for mutation and SNP analysis, including direct hybridization 
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(Chee et al. 2005; Kinoshita 2007), and ligation (Gunderson et al. 1998; Gerry et al. 1999; 
Broude et al. 2001; Hashimoto et al. 2005).  Inspired by the success of microarray on 
mutation and SNP analysis, many investigators adapted these microarray platforms to 
methylation analysis. In general, two major steps were involved in methylation research. 
The first step is to identify new methylation markers using gene expression (Suzuki et al. 
2002; Sato et al. 2003). The second step is to determine which genes among the candidate 
makers discovered in the first step are silenced by methylation and how they are 
associated with cancer or other diseases with microarray. Microarray-based methylation 
profiling techniques have been categorized into three types: bisulfite conversion based 
method, restriction enzyme cleavage based method, and immunology based method. In 
this chapter, the several major platforms of microarray will be reviewed for methylation 
profiling.  
2.2 Bisulfite Conversion Based Microarray 
2.2.1 Methylation-Specific Oligonucleotides Microarray 
In the methylation-specific oligonucleotides (MSO) microarray, methylated and 
unmethylated probes are designed from target DNA sequences with CpG sites, and 
immobilized on a solid support. This pair of methylated and unmethylated probes was 
hybridized with bisulfite PCR products via perfect match to evaluate the methylation 
status of a DNA sample (Adorjâan et al. 2002; Balog et al. 2002; Gitan et al. 2002). This 
direct hybridization based microarray potentially allows for rapid screening of the 
methylation status at numerous CpG sites within one or multiple genes of interest. After 
the bisulfite treatment and PCR, all Cs (not 5mCs) are replaced by Ts. This conversion 
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creates a nearly C-less sequence of mostly 3-base-DNA having predominantly A, G, and 
T (~50%). The reduction in sequence complexity facilitates the non-specific 
hybridization between probes and targets (Tusnady et al. 2005). The investigator 
developed strict criteria for probe selection, but the cross-hybridization of 
imperfect-match between probes and targets was still observed. Mund and co-workers 
tried 876 probes for the methylation analysis of P16 gene, and only 22 high 
discriminative probes were found to be good enough for the analysis at last (Mund et al. 
2005). The challenge is to select suitable sequences as probes with similar melting 
temperatures. Furthermore, to improve the specificity of hybridization, two or more CpG 
sites are included in one probe, which may lack the sensitivity to distinguish partially 
methylated sequences from fully methylated or unmethylated DNA. These limitations 
make it impossible to use MSO microarray for high-throughput methylation analysis. 
Although additional work was done to improve the specificity of hybridization by 
designing better probes (Kimura et al. 2005; Piotrowski et al. 2006), direct 
hybridization-based microarray is still not sufficiently robust for methylation analysis. 
The use of peptide nucleic acid (PNA) hybridization probes has been claimed to 
enhance the hybridization stability and sensitivity, but with this modification, the base 
composition and sequence influence the stability of the duplex (Griffin et al. 1997; Song 
et al. 2005). The high cost ($600/probe) is also another limitation for using PNA in large 
panels of microarray. 
2.2.2 Ligation Based Microarray 
Recently, two ligation-based microarray methods were developed for 
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methylation analysis (Bibikova et al. 2006; Cheng et al. 2006). Both of these two 
approaches use bisulfite conversion to create the C/T mutation sites for methylation 
research. The only difference between these two methods is PCR first or ligation first. In 
the first method, Barany and coworkers used traditional mutation and SNP detection 
method, PCR/Ligation, for multiplexed profiling of CpG island methylation status 
(Cheng et al. 2006). Briefly, it first utilizes two-run multiplexed PCR to amplify multiple 
target DNA sequences, followed by multiplex ligation reactions with two discriminating 
and one common ligation primers. The discriminating primers contain 5’ fluorescent label 
(Cy5/Cy3) and 3’ discriminating nucleotides corresponding to methylation or 
unmethylation CpG sites. The common ligation primers contain distinct zip-code 
sequences, which are designed with similar thermodynamic properties and high 
specificity. These unique zip-code sequences allow for the hybridization to be performed 
at the same temperature under more stringent conditions to reduce the non-specific 
interaction (Gerry et al. 1999; Fan et al. 2000; Favis et al.2000). Finally, the ligation 
products are analyzed using the zip-code universal microarray to determine the 
methylation status at each target CpG site. Using this assay, 75 CpG sites from 15 tumor 
suppressor genes are evaluated simultaneously. Furthermore, as the zip-code microarray 
can be easily expanded, additional CpG sites and genes can be added to the panel. 
In the second method (Bibikova et al. 2006), the investigators from Illumina 
apply their GoldenGate genotyping system to methylation analysis (Fan et al. 2000). This 
approach first utilizes ligation on a bisulfite-converted template to produce both 
methylated and unmethylated alleles, followed by multiplexed PCR to amplify the ligated 
sequences containing the target CpG site. The methylation status at each CpG site is 
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analyzed using a zip-code microarray as well. In this assay, a gap of 1-20 bases was 
designed between one pair of ligation primers to help sequence selection and to improve 
the specificity of primer-template annealing. The elongation with polymerase and ligation 
with ligase takes place simultaneously. Another advantage of this assay is the 
improvement of multiplex PCR efficiency. As the pairs of ligation primers have identical 
universal sequences, the multiplex PCR can be performed with only one pair of primers 
having universal sequences. This is different from the PCR/Ligation assay, where a 
number of primers are used in one reaction for amplification and the efficiency of each 
amplification varies greatly. In PCR amplification based assays, the PCR products are 
critical to the microarray analysis. Compared with direct hybridization based microarray, 
ligation based microarray improves specificity, allowing for methylation analysis of 
cancer cell lines or tumor tissues that contain a high abundance of tumor cells.  
2.2.3 Bisulfite Based Genome-Wide Microarray  
Due to DNA degradation in bisulfite treatment, PCR products have not been 
used for genome-wide methylation profiling. Recently, a novel whole-genome 
methylation profiling method, called BiMP (Bisulfite Methylation Profiling), was 
developed to amplify 100ng of bisulfite-converted DNA (Reinders et al. 2008). Unlike 
the standard whole-genome amplification method, BiMP reduces the length of the 
random primers from 6mers to 4mers to favor the priming of smaller DNA fragments, 
and to reduce the amplification bias for bisulfite-converted DNA. All of the random 
primers are labeled with the same sequences, which can be used as universal primers for 
the PCR amplification. As a result, improved uniformity of amplification of 
whole-genome was achieved. Finally, the PCR products are hybridized with standard 
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high-density oligo tiling microarray from Affymetrix. In the future, the detection can be 
performed on custom arrays with methylation-specific oligos as the design in MSO 
microarray. This new strategy should improve the sensitivity and specificity of BiMP.  
2.3 Restriction Enzyme Based Method 
Recently, many variations of restriction enzyme based methods were developed 
for methylation analysis, in particular for genome-wide methylation profiling (Tompa et 
al. 2002; Lippman et al. 2004; Lippman et al. 2005; Hatada et al. 2006 ; Khulan et al. 
2006; Schumacher et al. 2006; Yuan et al. 2006 ; Shann et al. 2008). Via the cleavage of 
either methylation-sensitive or methylation-insensitive restriction endonucleases, either 
methylated and unmethylated alleles can be enriched for large-scale analysis. All of the 
restriction enzyme based microarray can be assorted into three categories: digested and 
non-digested samples; digesting with methylation-sensitive and methylation-insensitive 
enzymes; digesting mutant and wild-type samples (Zilberman and Henikoff et al. 2007). 
2.3.1 Digestion and Non-Digestion  
As the most common approach, two portions of the same DNA sample are 
treated with or without restriction enzyme, followed by comparison of these two groups 
using microarray. Lippman et al. used the restriction enzyme McrBC, which prefers 
methylation DNA as a substrate, to selectively exclude the methylated fractions in whole 
sequence (Lippman et al. 2004; Lippman et al. 2005; Ordway et al. 2006). Then the 
enzyme treated DNA and non-treated DNA are gel-purified to keep the fragments bigger 
than 1kb, which are labeled with Cy5/Cy3, respectively. Labeled two portions are mixed 
together, and detected on one tiling microarray, which contains contiguous stretches of 
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chromosomes without bias to evaluate the methylation status of whole sequence 
simultaneously at high resolution. If the signal intensity from a non-treated sequence is 
higher than the treated sequence, this sequence targeted region is methylated. All 
methylated sequences are excluded by McrBC, whereas the non-treated sample retains all 
methylated DNA. In contrast, the unmethylated sequences can be excluded by 
TspRI-HpaII-ExoIII microarray assay, where DNA is digested with TspRI and HpaII, 
followed with ExoIII (Shann et al. 2008). Correspondingly, another portion of DNA is not 
treated with HpaII as control. These two portions of fragments are labeled with different 
dyes after the digestion for the microarray detection. 
To improve the sensitivity, Yuan et al. used Affymetrix SNP chip combing with 
methylation-sensitive restriction enzyme HpaII for methylation profiling (Yuan et al. 
2006). In the Affymetrix technology, PCR amplification with ligation adaptors reduces 
the required amount of DNA sample. In the assay, the sequences without methylation are 
cleaved with HpaII, and can not be amplified by PCR and can not be observed by the 
final array detection. The parallel DNA sample with HpaII digestion can serve as a 
control. With this improvement, only 600ng genomic DNA is required on 50K chips, 
instead more than 10μg needed for non-PCR amplification approach (Lippman et al. 
2005). Again, with PCR amplification, the DNA derived from formalin-fixed, and 
paraffin-fixed breast cancer tissue has been interrogated (Melnikov et al. 2008). This 
assay avoids degradation of the DNA sequence in bisulfite treatment for a limited clinical 
sample.  
2.3.2 Methylation-Sensitive and Methylation-Insensitive Enzymes Digestion 
As we described in Chapter 1, the methylation-sensitive restriction enzyme 
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HpaII, and methylation-insensitive isoschizomer MspI are most two common enzymes 
used in methylation analysis. Based on the digestion of these two enzymes, Khulan et al. 
developed a powerful method called HELP (HpaII tiny fragment Enrichment by 
Ligation-mediated PCR) for methylation profiling (Khulan et al. 2006). The HELP assay 
is based on the comparison of DNA samples digested by HpaII and MspI using 
microarray. Two portions of the DNA sample with high molecular weight are digested 
with HpaII and MspI, and ligated with an oligonucleotide pair on the site cleaved by 
restriction enzyme, respectively. Primed by these ligated oligonucleotides, the digested 
DNA can be amplified and labeled with different fluorescent dyes. Finally, the HpaII and 
MspI representations are hybridized on high density microarray. The ratio between these 
two representations can reveal the methylation status. The MspI representation provides a 
robust internal control to compare with HpaII representation, and detects the copy 
number of cancer cells, in which amplification and deletions are common. Furthermore, 
the HELP assay can be used on the other commercial microarray slides with the suitable 
combination of restriction enzyme isoschizomers for high-throughput genome-wide 
methylation profiling. Since more than 80% of all CpG islands are not related to 
regulation of gene expression, Hatada et al. developed more specific Microarray-based 
Integrated Analysis of Methylation by Isoschizomers (MIAMI) for promoter methylation 
profiling (Hatada et al. 2006). In this assay, lung cancer cell lines and normal lung cells 
are subjected to HpaII digestion, adaptor-ligation/PCR, followed by MspI digestion, and 
2nd PCR and labeling. With microarray detection, the HpaII resistance was calculated for 
both the cancer cell and normal cell lines. Moreover, another portion of lung cancer cell 
and normal lung cells are subjected to MspI digestion, followed by using the same 
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procedure as the HpaII digestion. With the microarray detection, the MspI resistance was 
calculated as well. After analysis of HpaII resistance and MspI resistance, threshold 
criteria was made to judge the methylation status of the microarray spots to the 
corresponding sequence in the promoter. Under this criteria, new epigenetic mutations 
can be detected in cancer cells.  
Instead of using single enzyme for DNA digestion, methylation-sensitive 
restriction enzyme cocktails were used to improve the resolution of detection 
(Schumacher et al. 2006). To enrich the unmethylated fraction, several combinations of 
methylation-sensitive enzymes, HpaII, Hin6I, AciI and HpyCh4IV were used to digest the 
genomic DNA, interrogating more than 41% CpG sites, followed by adaptor-ligation. 
McrBC was used to remove all of the methylated Cytosine in CpG sites. The cleaved 
methylated sequences can not be amplified or labeled. To enrich the methylated fraction, 
methylation-insensitive enzyme TasI or Csp6I was used for the digestion. After the 
adaptor-ligation, methylation-sensitive cocktails were used to remove the unmethylated 
CpG sites. Both of these two fractions were detected by microarray. This assay provides a 
useful tool for both hypomethylation and hypermethylation detection.  
2.3.3 Digestion of Mutant and Wild-Type Samples  
Comparison between the digestions of mutant and wild-type samples is the most 
common method in microarray. Yan et al. digested the tissue and wild-type control 
samples with MseI, followed by adaptor-ligation (Yan et al. 2001). Thereafter, the ligation 
DNA was digested with methylation-sensitive enzymes BstUI and HpaII. The tissue and 
wild-type control samples were labeled with different fluorescent dyes after the PCR 
amplification, and cohybridized on microarray, which is derived from a CpG island 
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library. Since the MseI fragments are not abundant in CpG islands, it was found that both 
non-CpG and CpG sequences were amplified. To improve the sensitivity and reduce the 
amplification of non-CpG sequences, a new adaptor-ligation method was used for 
methylation-specific amplification (Hatada et al. 2002). In this approach, the cancer cell 
lines and normal control samples were digested with methylation-sensitive enzyme SmaI 
firstly, followed by methylation-insensitive enzyme XmaI cleavage. Then, the 
adaptor-ligation takes place on XmaI cleaved sites. Hence, only methylated sequences 
could be amplified and detected by microarray. In addition, higher percentages of DNA 
fragments derived from hypermethylated loci were selected from the CpG island library.  
For the sample containing large amounts of DNA, Tompa et al. used MspI to 
digest the mutant sample and wild-type control, followed by size fraction to get 
fragments less than 2.5kb. The fractions of mutant and wild-type control without PCR 
amplification were labeled with different dyes for the direct microarray detection (Tompa 
et al. 2002). Recently, two other methylation-sensitive enzymes, HpyCH4IV and HpaII, 
were used for methylation profiling based on the same principle (Tran et al. 2005). 
2.4 Immunology Based Method  
The restriction enzyme based microarray requires high-molecular-weight DNA 
and is limited by the distribution of the restriction sites of the chosen endonucleases. For 
example, the HpaII sites only comprise 8% of the CpG sites in the human genome. To 
overcome these limitations, 5-Methylcytosine antibody or 5-Methylcytosine binding 
domain (MBD), immunoprecipitation and affinity chromatography followed by tiling 
microarray detection have been used for methylation profiling (Weber et al. 2005; Keshet 
et al. 2006; Zhang et al. 2006; Hayashi et al. 2007; Penterman et al. 2007; Zilberman et al. 
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2007). In the tiling microarray, nucleic acid probes can either overlap, lay end-to-end, or 
be spaced in the target genomic region. There can be classified into two major classes of 
tiling microarray on the basis of the fabrication of tiling microarray: oligonucleotide 
tiling microarray; PCR products or bacterial artificial chromosome (BAC) microarray. In 
the oligonucleotide tiling microarray, relatively short oligonucleotide probes (25-85bp) 
can be directly synthesized on the surface of the solid support by photolithography 
(Fodor et al. 1991; Pease et al. 1994), ink-jet device (Hughes et al. 2001; Wolber et al. 
2006), or programmable mirrors techniques (Singh-Gasson et al. 1999). This high-density 
microarray can provide 6.6 million spots in <2cm2. Alternatively, the synthesized 
oligonucleotide probes can be printed in low-density on the solid support by mechanical 
printer. In this low-density printing array, 10,000-40,000 spots can be spotted in single 
chip (1 inch X 3 inch). In the PCR products or BAC tiling microarray, the PCR products 
or BAC clones are printed on microarray array. 
2.4.1 PCR Products and BAC Based Tiling Microarray 
BAC tiling microarray has been used in comparative genomic hybridization 
(CGH) for identification of chromosomal imbalances and variation in DNA copy-number 
(Albertson et al. 2000; Snijders et al. 2001; Ishkanian et al. 2004). This quantitative and 
high-throughput technique is now attracting wide-spread interest, especially among 
methylation researchers. Weber et al. developed methylated DNA immunoprecipitation 
(MeDIP) combined with BAC tiling microarray for whole-genome as well as 
promoter-specific methylation analysis, where methylated DNA was captured by 
5-methylcytosine antibody, and hybridized to microarray to achieve a more unbiased 
analysis (Weber et al. 2005). In this assay, sheared genomic DNA between 300-1,000 bp 
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was incubated with the antibody against 5-methylcytosine. Then the captured methylated 
DNA fragments were isolated by immunoprecipitation using Dynabeads with antibody. 
The methylated DNA and input DNA (total DNA) were labeled with different fluorescent 
dyes for microarray hybridization. In the data analysis, the signal ratio of methylated 
DNA and input DNA could reveal the methylation status. In the BAC microarray 
fabrication, 32,433 BAC clones with 80Kb resolution in genome-wide, and 12,192 BAC 
clones derived from CpG island library were prepared for the slides printing. In this assay, 
the resolution and coverage of CpG sites are mainly determined on the microarray BAC 
fragments distribution, unlike the restriction sites of endonuclease.  
As an alternative, PCR products can be used for tiling microarray printing (Rinn 
et al. 2003; Odom et al. 2004). Combined with MeDIP, they were also used in 
genome-wide methylation analysis (Keshet et al. 2006). In the microarray fabrication, 
13,000 individual PCR amplifications derived from promoters were printed on array 
slides one by one. As in the case of the BAC tiling array, the input DNA and methylated 
DNA from immunoprecipitation were labeled with different dyes for microarray 
detection. After stringent analysis, the MeDIP based method can recognize the 
methylation region with the CpG density of larger than 2% and is ideally suitable for 
CpG island methylation detection. One has used this assay for colon cancer cell lines 
Caco-2 methylation analysis and a set of 135 gene promoters were found methylated, 127 
of which were contained in CpG islands.  
The problem with BAC and PCR tiling microarrays is that they are labor 
intensive. For example, in the tiling microarray fabrication for human chromosome 22, 
more than 20 000 PCR reactions must be designed to achieve a 1-Kb resolution (Rinn et 
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al. 2003). If the entire human genome tiling array was made in this way, more than two 
million PCR reactions are required (Royce et al. 2005). Hence, researchers generally 
adopted oligonucleotide based tiling microarray for methylation research.   
2.4.2 Oligonucleotide Based Tiling Microarray 
Tiling microarray can be classified into two groups on the basis of the length of 
oligonucleotides: short oligonucleotides (25-mer) from Affymetrix and long 
oligonucleotides (45-mer to 85-mer) from NimbleGen and Agilent. In the Affymetrix 
platform, each perfect-match oligonucleotide probe, alone with a single mismatch probe 
in the central base (position 13 of 25), is synthesized on glass slides using the 
photolithographic technology. The mismatch probe will provide a measurement of 
nonspecific target DNA binding to the perfect match. These short oligonucleotides 
improve the specificity, but suffer from decreased sensitivity, probe variability, and noise. 
To avoid these drawbacks, several stringent statistical methods have been developed for 
the data analysis, including the two-state hidden Markov model based on probe-level 
t-statistics (Carroll et al. 2005; Ji and Wong et al. 2005; Li et al. 2005), non-parametric 
Wilcoxon rank sum test (Cawley et al. 2004; Bernstein et al. 2005), and non-parametric 
Kolmogorov-Smirnov test (Zhang et al. 2006). In the long oligonucleotide microarray 
platform, only perfect match probes to genomic sequence are built on the microarray by 
photolithographic technology (NimbleGen), or ink-jet device (Agilent). These longer 
probes result in reducing the microarray density, but provide a better balance of 
specificity, sensitivity, and non-specific binding than the Affymetrix shorter platform 
(Kreil et al. 2006). Furthermore, the data derived from these long oligonucleotide 
platforms requires less statistical analysis. 
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With the Affymetrix platform, Zhang et al. reported the first comprehensive, 
high-resolution DNA methylation mapping of the Arabidopsis thaliana genome (Zhang et 
al. 2006). This whole genome tiling array contains ~6.4 million of 25-mer 
oligonucleotide probes for each 35 bp genomic region, which covers ~97% of one strand 
from five chromosomes (~120Mb). In the sample preparation, methylated DNA and 
unmethylated DNA were fractionated by MeDIP using 5-methylcytosine antibody, or by 
affinity chromatography using 5-Methylcytosine binding domain (MBD). Then, the 
fractions were subject to whole genome amplification and labeling with different dyes for 
microarray detection. The methylation patterns revealed in this method are consistent 
with previously individual loci analysis, and provide an invaluable reference for research 
in the individual loci from the genome in the future (Schöb and Grossniklaus 2006). 
Hiroshi et al. developed the tiling array covering ~30 Mb of human genome (1%), using 
Affymetrix platform (Hayashi et al. 2007). Combined with MeDIP, this unbiased, 
scalable, and detailed mapping technique was used for human colorectal cancer cell 
methylaiton profiling. As the tiling microarray for the whole human genome is being 
developed by Affymetrix, we can expect this will lead to a significant impact on human 
genome-wide methylation research. 
The group led by Henikoff successfully adopted the NimbleGen microarray from 
gene expression to plant methylation research (Mito et al. 2005; Mito et al. 2007; 
Penterman et al. 2007; Zilberman et al. 2007). Due to the large amount of DNA isolated 
from plant, the fractions of input and methylated DNA derived from MeDIP were labeled 
with different dyes and cohybridized on the tiling array without PCR. Using raw DNA 
can result in good results without the complicated statistical manipulation. Moreover, the 
 37
custom tiling arrays built by NimbleGen allows for the more flexible experimental 
design. 
Again, in human methylation research, this flexible tiling array system has 
shown great power recently. Weber et al. migrated from BAC tiling microarray to 
NimbleGen oligonucleotide microarray to study the impact of methylation on gene 
expression in human genome (Weber et al. 2007). In this study, ~16,000 high-confidence 
promoters in human primary somatic and germline cells and each with 15 
oligonucleotides were analyzed using MeDIP combined with tiling microarray. By 
mapping DNA methylation within the major human promoters, researchers that show the 
CpG island promoters with high ratio of CpG sites are mostly unmethylated, whereas the 
CpG-poor promoters are mostly hypermethylated in somatic cells. This comprehensive 
promoter methylation map provides intriguing insights into genome evolution, cellular 
differentiation, and their relation to tumorigenesis (Zilberman 2007). Later, Rauch et al. 
described another application of NimbleGen and Agilent platforms to high-resolution 
profiling of hypermethylation and hypomethylation in lung cancer (Rauch et al. 2007; 
Rauch et al. 2008). Briefly, methylated fractions were enriched by MBD proteins from 
lung squamous cell carcinomas and normal tissues extracted DNA, respectively. The 
fractions were cleaved by MseI digestion, followed by adaptor-ligation. After PCR 
amplification, these two fractions were labeled with different dyes for microarray 
cohybridization.  
2.5 Conclusion 
In this chapter, major microarray platforms can be grouped into three groups: 
bisulfite conversion, restriction enzyme, and immunology. Due to the significant losses 
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and cleavage of template DNA in bisulfite conversion, bisulfite based microarray is 
appropriate for the analysis for individual loci, specific genes, or specific sites. On the 
other hand, the conversion creates a nearly C-less sequence of mostly 3-base-DNA 
having predominantly A, G, and T. The reduction in sequence complexity facilitates the 
non-specific binding between bisulfite-treated template and probe (primer). It is difficult 
to maintain the specificity and sensitivity in genome-wide analysis. As alternatives, 
restriction enzyme and immunology based methods are capable for genome-wide 
methylation analysis, combined with high-resolution tiling microarray. The 
high-molecular-weight requirement and a limited number of recognizing sites for chosen 
endonucleases are the two drawbacks of restriction enzymes based microarray. To avoid 
these two limitations, 5-methylcytosine and MBD proteins based methods are developed 
for methylation analysis in genome-wide and promoters. All of the microarray platforms 
for methylation research are very young technologies at present. Undoubtedly, with 
development and refinement, these platforms hold great promises to unlock the 
relationship between cancer and methylation, as well as to provide valuable prognostic 
and diagnostic tools.  
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CHAPTER III  
MICROARRAY FABRICATION  
This chapter discusses how we fabricate home-made microarray. The 
commercial oligonucleotide microarrays manufactured by Affymetrix, Illumina, 
NimbleGen, and Agilent have facilitated research in gene expression, mutation detection, 
and genotyping. However, the cost and complexity of these platforms make them less 
adaptable by many researchers, who prefer printed microarray, which is more flexible in 
design and content, and potential cost saving over commercial arrays. Due to the 
technical variability in printed microarray, significant differences exist in microarray 
fabrication and post manipulation. In order to produce high quality microarray data, the 
following parameters have been extensively studied: solid supports selection, 
oligonucleotide modification, printing procedure optimization, fluorescent dyes selection, 
hybridization procedure optimization, and highly discriminative zip-code sequences 
selection.  
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3.1 Solid Support Selection and Spotting Optimization  
3.1.1 Solid Support Selection 
To develop reliable oligonucleotide microarrays, the immobilization of probes on solid 
support is one of the most essential and important subjects. A number of noncovalent and 
covalent methods can be used to immobilize oligonucleotides on solid support, which, in 
general, has two major forms: nylon membrane and glass slide. Due to the high 
fluorescent background, chemiluminescence is the most common detection method for 
nylon membrane. As the two-color or four-color fluorescent detection system is broadly 
used in microarray, glass slides with different functional surfaces are more suitable for 
fluorescence-based microarray. Glass as a support material has many advantages over 
other support: its non-porous structure requires low reaction volumes; it is durable to 
chemicals and high temperatures; low-background is very well suited for the 
fluorescence-based detection. The glass slides are commonly modified with several 
functional groups such as carboxyl (Lindroos et al. 2001), thiol (Rogers et al. 1999), 
poly-L-lysine (Schena et al. 1995), amine (Pack et al. 2007), aldehyde (Dawson et al. 
2005), and epoxy (Wrobel et al. 2003). In the noncovalent immobilization, the DNA can 
be fixed on the glass surface by acid-base interaction, hydrogen bonding, and electrostatic 
interactions. In contrast, the terminal covalent attachment allows the entire 
oligonucleotide to be available for hybridization and to withstand the high temperature 
and salt concentration often required during the stringent washing conditions in 
subsequent steps of microarray processing. Hence, to yield reproducible results, covalent 
immobilization was used in our platform development. Direct covalent coupling is most  
 41
commonly achieved using amino-terminated oligonucleotides and either aldehyde or 
epoxy modification glass. For these reasons, this study focused on the immobilization of 
amino-terminated oligonucleotides to aldehyde and epoxy modified glass slides.  
First, epoxy or aldehyde slides (CEL Associates, Pearland, TX) were printed, 
blocked, and washed under the same conditions. Then, mini-sequencing products were 
hybridized with the immobilized oligonucleotides under the same condition. In Fig. 3, it 
is seen that the background of epoxy is much stronger than aldehyde slides, although 
there was no significant difference between the strength of signals. The reason for the 
high background is the different property of these two modifications. The aldehyde 
surface is hydrophilic, whereas the epoxy surface is hydrophobic. The fluorescent dyes, 
modified from ddNTP or dNTP, mostly are hydrophobic. After the hybridization, it is 
difficult to clean the surface. Hence, we preferred aldehyde modification to epoxy 
modification. The aldehyde slides made by different companies such as Erie Scientific, 
CEL, Corning, and TeleChem were tested. Finally, CEL aldehyde slides were chosen in 
this thesis work for their high binding capacity, low background, and cost-saving 
features. 
3.1.2 Optimization of Spotting, Immobilization, and Wash Conditions 
Several recent studies that investigated immobilization of short 
NH2–oligonucleotides on aldehyde–glass employed a number of vastly different 
protocols for spotting and processing of microarray slides (Lindroos et al. 2001; Booth et 
al. 2003; Al-Khaldi et al. 2004; Hou et al. 2004; Deyong 2005). In these protocols, 
different immobilized solutions are used, such as DMSO, SSC, alkaline phosphate, 
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                           A                        B 
Fig. 3 Modified glass selection. (A)Aldehyde modification glass support and (B) epoxy 
modification glass support were immobilized, blocked, and washed under the same 
condition and hybridized with the same SBE products. 
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sodium carbonate, and some commercial solutions. Furthermore, different temperature 
(from room temperature to 75 oC), humidity (from <30% to 100%), and time (from 15min 
to 48h) were used in the printing. These examples demonstrate a clear need to investigate 
a number of variables in oligonucleotide microarray fabrication and processing 
procedures, as it is impossible to compare the results of similar experiments conducted 
under such vastly different conditions. 
Laura R. Kuck and co-worker tested and compared different types of spotting buffer and 
chose 3XSSC/0.05% SDS/0.001% Chaps as the spotting buffer, which was also used in 
our studies (Dawson et al. 2005). After printing, glass slides were kept for 24 hours at 
room temperature in the hood (humidity <30%), a sealed container with saturated NaCl 
solution, and a sealed container with water respectively. All of these slides were blocked, 
washed, and hybridized under the same condition. We found that under the low humidity 
the printing spots were not uniform. And the spots formed ‘donut’ circles without signals 
in the center. When we increased the humidity using saturated NaCl solution and pure 
water, the donut disappeared gradually (Fig. 4 A). Hence, saturated humidity must be 
kept in the post-spotting process to improve the reaction between oligonucleotides and 
the modified surface. To optimize the post-spotting temperature, we studied the slide 
performance at room temperature, 37oC, and 55 oC for 12 hours, and 80 oC for 1 hour, 
respectively. We didn’t find any significant difference except for the higher temperature 
inducing high fluorescent backgrounds. The reason for this could be that after the 
incubation at high temperature, the salt and oligonucleotides changed the surface of spot 
area, which was displayed as a fluorescent signal under high sensitivity scanning. We did 
the blank test at room temperature and 80 oC, respectively. The later condition showed  
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 Fig. 4 Post-printing humidity and temperature selection. (A) Humidity Test: less than 
30% humidity at room temperature (left); the humidity of saturated NaCl solution at 
room temperature (middle); the humidity of water at room temperature (right). (B) Blank 
Test: printed slides were left at room temperature for 12 h (left); printed slides were 
baked at 80 oC for 1 h (right). 
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high background and produce the false-positive signal in the test (Fig. 4 B). Hence, we 
performed the post-spotting at room temperature for 12-48 hours. In the blocking and 
washing step, the excess of aldehyde-reactive groups were deactivated by keeping the 
slides for 25 min at room temperature in Pronto™ pre-soak solution (Corning, NY), 
followed by washing with buffer I and II of Pronto™ Universal Microarray Validation kit 
(Corning, NY).  
3.2 Oligonucleotide Modification Optimization  
In this study, we attached an amino group to all of the oligonucleotides. The 3’ 
terminal or 5’ terminal could be chosen as modification site. To reduce steric interference 
from the solid surface that affects the hybridization between probes and targets, the 
immobilized oligonucleotides must be lifted up from the surface. When the 
oligonucleotides were synthesized, C3, C5, C6 or C12 was linked to amino to increase 
the space (Gerry et al. 1999; Gitan et al. 2002; Moreno et al.2006). C6 and C12 linkers 
are the most common in the microarray. In order to increase the space, a spacer consisting 
of a poly thymine chain up to 15 bases in length was added in the synthesis (Lindroos et 
al. 2003; Hultin et al. 2005; Pourmand et al. 2007). In our study, C3, C6, C12 linkers and 
15T spacer were tested. We chose one oligonucleotide, which was synthesized with 
different carbon linkers to hybridize with the same PCR product. The strongest signal 
was C3 amino linker, and the weakest signal was C12 amino linker (Fig. 5). Five 
different oligonucleotides were tested by this way, and the same result was seen. The 
reason for this gradual change is probably the hydrophobic property of C12 and the 
hydrophilic property of aldehyde surface. Another reason is the solubility of C12 linker in 
the spotting buffer. The C12 linked to amino makes it difficult to dissolve amino in the  
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 Fig. 5 Carbon linker selection. C3, C6, and C12 linkers comparison: the same 
oligonucleotide with different carbon linkers were synthesized in the amino modification. 
Each oligonucleotide was printed 10 times on the same aldehyde slide, then hybridized 
with the same PCR product. 
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spotting buffer. As a result, the amino and aldehyde reactive group on the slides were not 
fully contacted. This decreased the immobilized efficiency of an amino modified 
oligonucleotide on aldehyde slides.   
15T spacer was also tested with 6 oligonucleotides, three of which included 15T 
spacer and three of did not. No significant difference was found by us. Again, in our 
SBE-TAGs and CHZMA platforms, the hybridization efficiency was not influenced by 
15T spacers. Hence, in the universal zip-code microarray, oligonucleotides were 
synthesized with a 3C linker and without a 15T spacer. 
3.3 Fluorescent Dyes Selection  
As an alternative to radioisotopic labeling, fluorescent labeling enables the 
signal detection with a high resolution in microarray. On the other hand, the combination 
of multiple fluorescent dyes used in a single reaction became available for the sequence 
variation changes detection such as SNP and methylation. Two kinds of labeling, direct 
and indirect, are used in the microarray system. In the direct labeling, fluorescence 
modified oligonucleotides, ddNTPs, and dNTPs can be incorporated into DNA strands by 
enzymatic reactions, such as PCR, ligation, SBE (Gitan et al. 2002; Lindroos et al. 2002; 
Bibikova et al. 2006; Cheng et al. 2006). In the indirect labeling, biotin or aminoallyl 
modified oligonucleotides, ddNTPs, and dNTPs can be incorporated into DNA strands by 
enzymatic reaction, followed by conjugating with fluorescent dyes using chemical or 
enzymatic reactions (Hoen et al. 2003; Zhang et al. 2006). Generally, four-color 
fluorescent labeling is used in the SNP and mutation detection and two-color and 
single-color fluorescent labeling are used in the methylation detection.  
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Due to the fact that different dyes have considerable differences in their  
photostabilities and fluorescence efficiencies, fluorescein, Texas-red, Cy3, and Cy5 were 
tested by us on a laser-induced fluorescence system, Typhoon 9410, which has four lasers 
including: 457nm, 488nm, 532nm, and 632nm. All of these four dyes are equally 
separated on the major fluorescent area from 400nm to 750nm with minimal overlap (Fig. 
6). Using single-base extension, we tested several combinations of these four dyes for 
methylation analysis. The combinations are listed in Table I. After the comparison, 
Combination 3 is determined to be the best candidate for our methylation analysis. As an 
addition, combination 5 is another good candidate except for the low fluorescent 
efficiency of fluorescein. 
The problems of Combination 1 are that fluorescein has low excitation efficiency 
(83000), and Texas-red does not have a matched laser for excitation. In Typhoon 9410, 
Texas-red is excited by a 532nm laser, which is far from the optimum absorption (583nm) 
of Texas-red. With the same problem of Texas-Red, Combination 4 is not a good 
candidate either. 
We next compared Combination 2 with Combination 3, where unmethylated 
PCR product was used as template for SBE in the presence of Cy5 ddATP and Cy3 
ddGTP (Combination 2) or Cy5 ddGTP and Cy3 ddATP (Combination 3). In the SBE 
reaction, only Cy5 ddATP is incorporated into extended products with the unmethylated 
template in the case of Combination 2. But as shown in Fig. 7, both Cy3 and Cy5 
channels show signals after we scanned array slide with 583nm and 632nm lasers, 
respectively. The reason for this is that Cy5 ddATP can be excited by both 583nm and 
632nm lasers, but the signal from 583nm laser is corresponding to the methylation  
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 Fig. 6 Fluorescence spectra of selected dyes. Absorption and emission of fluorescence 
Spectra: broken line is for the absorption peak and solid line is for the emission peak; 
Green, red, black, and blue are corresponding to fluorescein, Texas-red, Cy3, and Cy5, 
respectively. 
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Table I. Different combinations of ddATP and ddGTP were studied in the 
SBE reaction. 
 Combination 1 Combination 2 Combination 3 Combination 4 Combination 5 
ddATP Texas-red Cy5 Cy3 Texas-red Cy5 
ddGTP Fluorescein Cy3 Cy5 Cy5 Fluorescein 
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 Fig. 7 ddATP and ddGTP fluorescent labeling selection. Combination 2 and 3 were 
used for the SBE reaction using unmethylated PCR product as the template. After 
hybridization, microarray slides were scanned in Cy5 (632nm) and Cy3 (583nm) 
channels, respectively. 
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detection. This can lead to false-positives for the methylation evaluation. Hence, 
Combination 2 can not be selected for the SBE reaction. In contrast, using Combination 3 
for the SBE reaction with unmethylated template, only Cy3 channel has signal. No signal 
was found in Cy5 channel because Cy3 ddATP can not be excited by the 632nm laser. 
3.4 Hybridization Optimization  
Hybridization between single-stranded probes and target molecules occur 
through hydrogen bonds formation between the bases of complementary nucleic acid 
sequences. Sequence composition, target and probe length, hybridization temperature, 
secondary structure, degree of homology, salt concentration, pH, and a number of other 
factors influence the hybridization efficiency and the strength of the double helix 
structure. LifterSlip system (Erie scientific, NH) and ProPlate™ Multi-Array Slide 
System (Grace Bio labs, OR) were compared for the hybridization. The LifterSlip system 
uses 15~23μL hybridization volume and 3 areas in a slide. The ProPlate™ Multi-Array 
Slide System uses 40~200μL hybridization volume and 16 areas in a slide. Under the 
same condition, High background was detected in the LifterSlip system (Fig. 8 A). After 
8~12 hours hybridization, unknown substances bond to on the surface of the array slide. 
Hence, we used ProPlate™ Multi-Array Slide System for the hybridization of our 
home-made microarray. 
We next studied the hybridization buffers. SSC series buffer, SlideHyb buffer 
(Ambion, TX), Pronto™ short oligo hybridization buffer (Corning, NY), and PCR buffer 
(GE healthcare, NJ) were tested. High background and poor signal were detected in the 
first two hybridization buffers. Low background and high discrimination were seen by  
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A 
 
B 
 
Fig. 8 Microarray hybridization condition optimization. (A)LifterSlip hybridization 
system and ProPlate™ Multi-Array Slide System comparison: the left is LifterSlip 
system with higher background and the right is ProPlate™ Multi-Array Slide System. (B) 
Coring hybridization buffer (right) and GE healthcare PCR buffer (left) comparison. 
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using Coring buffer. Low background and strong signal were detected by using PCR 
buffer. As seen from Fig. 8 B, the signal from the PCR buffer is stronger than that from 
Coring buffer, but with more crosslink and nonspecific binding between different 
sequences. Hence we selected Pronto™ short oligo hybridization buffer as our 
hybridization buffer. 
In the universal zip-code microarray, all of the zip-code sequences immobilized 
on the slides are 23 bases, with the melting point of 62~66oC. In order to obtain the 
optimal hybridization temperature to achieve the sufficient specificity, we tested the 
hybridization from 38 oC to 63 oC. Finally, 54 oC was selected for this group of zip-code 
probes. 
3.5 Highly Discriminative Zip-Code Sequences Selection 
A highly discriminative and specific sequence is the critical factor for the 
microarray. To design the zip-code sequences, all possible 20~24 mers were subject to a 
computational screen to generate a set of sequences with similar GC content, 
thermodynamic properties, and minimal cross-hybridization (Gerry et al. 1999; 
Shoemaker et al. 1996; Giaever et al. 1999; Winzeler et al. 1999; Favis et al. 2000). 
However, individual oligonucleotides still differ in their performance. It is not possible 
currently to predict all of the performance parameters of particular probes in microarray 
experiments simply by theoretical calculations (Pozhitkov et al. 2006). In our low density 
tag microarray, we must ensure that the methylation status of each gene or each specific 
region. As a result, stronger and more specific interactions between the zip-code 
sequences and complement zip-code sequences are required.  
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The strategy to select highly discriminative sequences is illustrated in Fig. 9. In  
the selection, all of the candidate zip-code oligonucleotides with 3C amino linker at 3’ 
terminal (MWG-Biotech Inc., AL) were printed on aldehyde modified microarray slides 
(CEL, TX) with XactII Compact Microarrayer (LabNEXT Inc., IL). In the SBE reaction, 
a chemically synthesized single-strand oligonucleotide was used as the template for all of 
the candidate sequences. All SBE primers are designed with the identical gene-specific 
sequence for the chemically synthesized template and different candidate zip-code 
sequences. All of the SBE for different sequences were performed in individual tubes and 
the hybridization took place in a different subarray area. Typically, the selection criteria is 
that the signal from a perfect match spot is at least 10 folds higher than the signal from a 
mismatch spot. We were able to select 32 discriminative and specific zip-code sequences 
from 70 candidates for the fabrication of a universal tag microarray. The sequences of 32 
zip-code are listed in the Appendices. 
3.6 Conclusion 
In this chapter, we describe the study of the fabrication of our home-made 
microarray. It generates the standard procedure for our future research. First, the highly 
discriminative tag probes (MWG-Biotech Inc., AL) are synthesized with 3C amino 
modification at 3’ terminal without poly-T spacer. Second, the probes are dissolved in the 
printing buffer of 3XSSC/0.05% SDS/0.001% Chaps, and printed on aldehyde modified 
microarray slides (CEL, TX) with XactII Compact Microarrayer (LabNEXT Inc., IL). 
After spotting, the printed slides were incubated in a container with the saturated 
humidity of water at room temperature for 12-48 h. Then, the printed slides are placed in  
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 Fig. 9 Schematic outline for highly discriminative tag selection. A chemically 
synthesized single-strand oligonucleotide is used as the template for SBE reaction of tag 
selection. The SBE primers are designed with the identical gene-specific sequence 
(highlighted in blue) and different tag sequences including: tag 1, tag 2, and tag 3. In the 
SBE, all tag primers are added to different tubes for the cyclic reaction separately. 
Correspondingly, the hybridization is performed in different subarray area for each tag 
primer separately. For example, if the SBE primer with tag 1 (highlighted in red) is 
detected at the position of anti-tag 1 on the microarray, tag 1 is thus highly discriminative. 
Contrarily, in the tag 2 selection, if two positions of anti-tag 2 and anti-tag 3 are all 
detected with positive signal, then tag 2 has low discrimination. 
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the desiccator for future use. Before the hybridization, the excess of aldehyde-reactive 
groups are deactivated by placing the slides in Pronto™ pre-soak solution (Corning, NY) 
for 25 min at room temperature, followed by washing with buffer I and II in Pronto™ 
Universal Microarray Validation kit (Corning, NY). Third, in the two-color microarray 
system, Cy5 and Cy3 can be used for the labeling of methylation and unmethylation 
signal, respectively. Fourth, the hybridization of microarray slides can be processed on 
ProPlate™ Multi-Array Slide System (Grace Bio labs, OR) using Pronto™ short oligo 
hybridization buffer (Corning, NY) at 54 oC for 3-12 h. Fifth, the array slides are rinsed 
with SSC buffer and ddH2O, and scanned in a laser-induced fluorescence system, 
Typhoon 9410. And the data is analyzed by ImageQuant or ArrayVision.  
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CHAPTER IV 
MULTIPLEX METHYLATION ANALYSIS BY SBE-TAGS 
MICROARRAY 
4.1 Abstract 
DNA methylation analysis plays a pivotal role in unlocking association of 
epigenetic events with cancer. However, simultaneous evaluation of the methylation 
status of multiple genes is still a technical challenge. In this work, we describe the use of 
SBE-TAGs microarray for the simultaneous determination of methylation status of 
multiple genes. 10 CpG sites of 9 tumor suppressor genes (MGMT, GATA4, HLTF, 
SOCS1, p16, RASSF2, CHFR, TPEF, and Reprimo) were selected for this study. We 
found that SBE-TAGs microarray performed quite well in multiplex methylation analysis 
if a standard calibration curve method was used. In addition, SBE-TAGs is robust and 
reproducible. Hence, this work suggests that SBE-TAGs microarray can be a 
high-throughput method for multiplex methylation analysis. 
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4.2 Introduction 
DNA methylation is a key event regulating gene expression. In vertebrates, the 
majority of 5'-methylcytosine occur at CpG sites within the promoter, often resulting in 
transcriptional inactivation of genes (Huang et al. 1999; Jones and Laird 1999; Toyota et 
al. 1999; Bird 2002). The hypermethylation of the promoter regions of some genes plays 
a pivotal role in the governance of normal and disease development (Baylin et al. 1998). 
It was found that in cancer, promoter hypermethylation is one of the most common 
mechanisms for the loss of function of tumor suppressor genes. In virtually every type of 
human neoplasm, promoter methylation is found to be associated with the inappropriate 
transcriptional silencing of genes (Baylin and Herman 2000; Warnecke and Bestor 2000). 
Because of the enormous potential of epigenetic markers in both cancer screening and 
treatment, considerate effort was made to search for methylated genes that can be novel 
therapeutic targets or screening biomarkers (Hayatsu et al. 1970; Frommer et al. 1992; 
Herman et al. 1996; Sadri et al. 1996; Gonzalgo and Jones 1997; Xiong and Laird 1997; 
Eads et al. 2000; Cottrell and Laird 2003; Tost et al. 2003; Zeschnigk et al. 2004). 
Most of existing methods for methylation analysis are based on bisulfite 
treatment that converts cytosine to uracil whereas the methylated cytosine residues are 
unaltered. The treated DNA is then PCR amplified to yield fragments wherein Ts replace 
Us (former Cs), and Cs replace the methylated Cs. Thereafter, the methylation status of 
the target DNA is examined using conventional DNA analysis methods. Currently, 
methylation-specific PCR (MSP) is the method of choice for methylation analysis 
(Herman et al. 1996; Cottrell and Laird 2003), which utilizes methylation-specific 
primers to discriminate methylated DNA from unmethylated DNA in PCR. MSP is 
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sensitive and can detect one methylated allele in a large background of unmethylated 
alleles. Its real time PCR variation can also quantify the abundance of methylated DNA 
(Zeschnigk et al. 2004). However, its problem is low throughput. In general, one MSP 
reaction reveals methylation of a gene at a time.  
Microarray is a method for multiplex analysis. Attempt has been made to use 
microarray for high-throughput methylation analysis (Gitan et al. 2002; Kimura et al. 
2005; Bibikova et al. 2006; Cheng et al. 2006; Piotrowski et al. 2006). The conventional 
application of microarray to methylation analysis involved direct hybridization, utilizing 
oligonucleotide probes designed to target either the methylated or unmethylated alleles 
within target sequences (Gitan et al. 2002). However, its poor specificity makes it 
impossible for it to be used in routine methylation analysis. It is not totally surprised to 
see that it is a challenge to apply microarray to methylation analysis. This is because 
bisulfite treatment eliminates all Cs in unmethylated DNA and in non-CpG sites of 
methylated DNA and thus creates a nearly all C-less sequence of most 3-base-DNA 
having predominantly A, G, and T. This reduction in sequences, relative to normal 
4-base-DNA, makes hybridization less specific. Because of this problem, each of the 
conventional genetic analysis methods must be carefully examined to determine if it is 
suitable for methylation analysis.    
Recently, we conducted a systematic study to examine the use of microarray 
methods for methylation analysis and one of the methods that we tested was SBE-TAGs 
microarray, which was originally developed for SNP analysis (Pastinen et al. 1997; 
Hirschhorn et al. 2000; Lindroos et al. 2002; Lovmar et al. 2003; Favis et al. 2004; Fan et 
al. 2006). We found that SBE-TAGs microarray performed quite well in methylation 
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analysis and could reveal the methylation status of the individual CpG sites, thus the 
methylation status of the corresponding genes. Importantly, SBE-TAGs microarray 
allows for the simultaneous determination of the methylation status of multiple genes. In 
addition, SBE-TAGs microarray is robust and reproducible. Clearly, this study 
established that SBE-TAGs microarray is an effective microarray method for multiplex 
methylation analysis.  
4.3 Materials and Methods 
4.3.1 Samples and DNA Isolation 
Unmethylated control genomic DNA and methylated control genomic DNA 
were purchased with CpGenomeTM DNA modification Kit (Millipore, Billerica, MA). 
The mixture samples containing both methylated and unmethylated DNA were created by 
spiking methylated DNA control genomic DNA into unmethylated control genomic DNA 
at a given ratio. The colorectal carcinoma cell lines HCT116 and HTB38 were cultured 
under standard conditions and genomic DNA were extracted from the cells using 
QIAamp DNA mini kits (QIAGEN, Valencia, CA) according to the manufacturer’s 
protocol. 
4.3.2 Bisulfite Treatment  
The CpGenomeTM DNA modification Kit (Millipore, Billerica, MA) was used 
for bisulfite treatment in this study. Bisufite treatment was performed using the protocol 
suggested by the manufacturer. The only exception was the desalting and desulfonation 
step. Briefly, after bisulfite treatment for 15 h at 50oC, a 50K Microcon centrifuge column 
(Millipore, Billerica, MA) was used in desalting, followed by washing the column 3 
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times with 500μL ddH2O on Eppendorf Centrifuge 5415C (Eppendorf North America, 
Westbury, NY) at 9000RPM . In the desulfonation step, we transferred 500μL of 
0.1MNaOH solution to the column, and then spun it until the solution went through at 
3000RPM. The column was then washed twice with 500μL of ddH2O and 1 time TE 
buffer. Finally, the modified DNA was recovered from the column. The converted DNA 
was used immediately or stored at -20oC for further analysis. 
4.3.3 Multiplex PCR 
The first PCR contained 2μL of bisulfite-converted DNA, 300-400nM of each 
primer, 1× AmpliTaq Gold PCR buffer, 400 μM of each dNTP, 4 mM MgCl2, and 2.5 U 
AmpliTaq Gold polymerase (Applied Biosystems, Foster City, CA). The first run of PCR 
was performed at 95oC for 10min, then 42 cycles of 95oC for 30 sec, 58oC for 45 sec, 
72oC for 45 sec and a final extension at 72oC for 5 min on iCycler Thermal Cycler 
(Bio-Rad Laboratories, Hercules, CA). The second run of PCR contained 0.5μL of 
template DNA produced from the first PCR, 400 nM universal primer (T3 
AATTAACCCTCACTAAAGGG; T7 GTAATACGACTCACTATAGG), 1× AmpliTaq 
Gold PCR buffer, 400 μM of each dNTP, 4 mM MgCl2, and 2.5 U AmpliTaq Gold 
polymerase. The second PCR were carried out at 95oC for 10min, then 35 cycles of 95oC 
for 30 sec, 57oC for 30 sec, 72oC for 30 sec and a final extension at 72oC for 5 min.  
4.3.4 Multiplex SBE 
The final PCR product (4μL) was first treated with 1U/μL Exonuclease I and 
0.1U/μL shrimp alkaline phosphatase (USB Corporation, Cleveland, OH) at 37oC for 60 
min, followed by inactivation of the enzyme at 95oC for 10min. The SBE reaction was 
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performed in a multiplex manner, containing all SBE primers (10nM each), 0.1μM of 
Cy3-ddATP, 0.1μM of Cy5-ddGTP (PerkinElmer,Waltham, MA), 0.05U/μL of 
ThermoSequenase, 1× SBE buffer (GE healthcare, Piscataway, NJ). The cyclic reactions 
were performed for 94oC 5min, followed by 60 cycles of 94oC and 55oC for 30 sec each. 
4.3.5 Array Fabrication  
Microarray used was home-made. Briefly, synthetic oligonucleotides with 3C 
amino linker at 3’ terminal (MWG-Biotech, Piscataway, NJ) were dissolved in 3XSSC, 
0.05% SDS, and 0.001% Chaps (Sigma-Aldrich, St. Louis, MO) spotting solution, as this 
buffer could improve immobilization of oligonucleotides on an aldehyde modified slide 
(CEL Associates, Pearland, TX). The oligonucleotides were spotted on the slides using 
XactII Compact Microarrayer (LabNEXT Inc., Glenview, IL). After printing, the slides 
were placed in a box at a 75%~100% relative humidity for 12~72 h at room temperature. 
Then, the excess of aldehyde-reactive groups were deactivated by incubating the slides 
with Pronto! Pre-Soak solution (Corning, NY) for 25 min., followed by washing the 
slides with dH2O several times.  
4.3.6 Hybridization 
After SBE, 1μL of the SBE product, 1μL of 10mg/ml salmon sperm DNA, 8μL 
of 10×PCR buffer (GE healthcare, Piscataway, NJ) that was used as hybridization buffer, 
and 70μL of dH2O are mixed together, followed by denaturing the mixture solution at 
95oC for 5 min. Then, the solution was added to the ProPlate™ Multi-Array Slide System 
(Grace Bio-Labs, Bend, OR) and incubated with the slide at 56oC for 3~5 h. After 
hybridization, the slides were rinsed with 2×SSC, 1×SSC, 0.5×SSC, and ddH2O, 
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respectively. Finally, the slides were spun dry immediately for 5 min at 200×g before 
signal detection.   
4.3.7 Signal Detection and Data Analysis  
Fluorescence signal from each spot of microarray was detected with Typhoon 
9410 (GE healthcare, Piscataway, NJ) using the excitation laser: Green (532 nm) and Red 
(633 nm). The images acquired by the scanner were analyzed with the software 
ArrayVision 8.0 (GE healthcare, Piscataway, NJ). The signal intensity from each spot was 
corrected by subtracting the average background from the mean average intensity for 
each spot. The data generated from ArrayVision was exported to Microsoft Excel for 
further analysis. The methylation level of a target CpG site was calculated by dividing the 
methylation signal intensity (Cy5 signal) by the sum of the signal of both methylation 
(Cy5) and unmethylation (Cy3): Percentage of Methylation = Signal 
Cy5/(SignalCy3+SignalCy5). 
4.3.8 MALDI-TOF Based Mini-Sequencing 
MALDI-TOF based mini-sequencing was used to verify the result of SBE-TAGs. 
Briefly, mini-sequencing was first carried out in the presence 0.2μM of ddA, ddT, and 
ddC, and 1μM of dG. The concentration of each mini-sequencing primer is 200nM. Other 
mini-sequencing conditions were similar to those used in SBE. Thereafter, the MALDI 
sample was prepared as described previously (Sun et al. 2000). The sample was then 
analyzed using MALDI-TOF (Bruker Daltonics Inc., Billerica, MA). The negative ion 
mode was used to collect all spectra.    
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4.4 Results and Discussion 
4.4.1 Assay Design  
SBE-TAGs microarray was originally developed for multiplex SNP genotyping. 
In this work, we modified it for multiplex methylation analysis. Fig. 10 displays the 
schematic representation of multiplex methylation analysis with SBE-TAGs microarray. 
Briefly, a sample is first subjected to bisulfite treatment that converts cytosine to uracil 
whereas the methylated cytosine residues are unaltered. The treated DNA is then 
amplified by two-runs of multiplex PCR to yield DNA fragments wherein Ts replace Us 
(former Cs), and Cs replace the methylated Cs. Thereafter, the methylation status of each 
target CpG site is determined using SBE-TAGs microarray, in which single base 
extension (SBE) is performed involving extension of a SBE primer located adjacent to 
the C position of a target CpG site using DNA polymerase in the presence of the 
fluorescence labeled Cy3-ddATP and Cy5-ddGTP, resulting in extension of the 
methylated allele by Cy5-ddGTP and extension of the unmethylated allele by 
Cy3-ddATP.  
The detection of SBE products is achieved with a tag array. Briefly, a unique 
sequence tag is added to the 5’ end of each SBE primer, allowing for specific 
hybridization with one probe spotted on the microarray. Each of the spotted probes is 
complementary only to one sequence tag added to the SBE primers. As a result, all SBE 
reactions can be distinguished and detected by a single microarray. 
10 CpG sites in 9 different genes were studied to examine the performance of 
SBE-TAG microarray. In this study, we use only one SBE primer to target one CpG site 
in each gene, except for p16 in which two SBE primers were used to target two different 
 66
 Fig. 10 Schematic representation of SBE-TAGs microarray for multiplex 
methylation analysis. Two hypothetical CpG sites 1 and 2 are designed as methylated 
and unmethylated, respectively. After bisulfite conversion, all of modified DNA template 
is amplified by using the primers containing the gene-specific 3’ portion and an upstream 
universal sequence (highlighted in blue) in the first PCR. Introduction of this universal 
sequence allows for the amplification of all target sequences in the second PCR by using 
the same universal primers. In the multiplex SBE reactions, the SBE primers, one for 
each target CpG site, are extended in the presence of Cy5-ddGTP and Cy3-ddATP, where 
Cy5-ddGTP is added to the SBE primers when the allele is methylated, while Cy3-ddATP 
is added to the SBE primers if the allele is unmethylated, respectively. Each SBE primer 
is also tagged with one specific sequence tail that is fully complementary to the sequence 
of a detection probe spotted on microarray. The labeled SBE products are analyzed by 
microarray. The methylation status of a target CpG site is determined on the basis of the 
signals of Cy5 and Cy3 emitted from its corresponding spots on microarray. 
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CpG sites. 
4.4.2 Multiplex PCR Amplification and SBE 
Multiplexed PCR is essential to multiplex methylation analysis, but multiplexed 
PCR of the bisulfite treated DNA is a challenge. Bisulfite treatment eliminates all Cs in 
unmethylated DNA and in non-CpG sites of methylated DNA and thus creates a nearly all 
C-less sequence of most 3-base-DNA having predominantly A, G, and T. This reduction 
in sequences, relative to normal 4-base-DNA, makes multiplexed PCR of bisulfite treated 
DNA difficulty. A two-run PCR strategy is used in this work. The first PCR primers have 
both a target-specific part and universal tail part. The target-specific part allows for 
amplification of a specific sequence, while the tail part introduces the universal 
sequences for the second run of PCR that employs universal primers complementary to 
the tail parts introduced by the first run of PCR. The T7 and T3 sequences were used as 
the universal tail of the forward and reverse primers for the second PCR, respectively. 
The target-specific part of the first PCR primers was designed to tolerate internal CpG 
sites to allow its hybridization to both methylated and unmethylated sequences. Because 
the first run of PCR is intended to produce sufficient amounts of methylated DNA 
molecules for the enrichment step (note that amplification is mainly achieved in the 
second run of PCR in this two-staged multiplexing PCR strategy), its amplification is not 
requested to be as efficient as conventional PCR. As a result, this reduces the difficulty of 
designing the PCR primers. In general, the target-specific part of the primers was 
designed to target the regions containing a number of cytosines, but without CpG sites. 
When the CpG site cannot be avoided in some cases, the PCR primers were designed to 
contain both C and T or both G and A in the C position of the CpG sites. Table II lists 9  
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Table II List of the Sequences of the Primers Used in the First PCR. 
Primer 
 
Set 
Forward Primer Reverse Primer  Size 
(bp)
MGMT T7-TTTYGGATATGTTGGGATAGTT  T3-AAACRACCCAAACACTCACCAAATC 109
GATA4 T7-GGTTTGTTTTATTTTTAGGGCGGAGG T3-CATCCCGAACTACCCTACTAAATCCC 119
HLTF T7-GTTGGTTATTAGAGGGTGGGGCGGA T3-AACCGAAAACTCCATACTACTCCCC 124
SOCS1 T7-GAGTTYGTGGGTATTTTTTTGGTG  T3-ACTACCATCCAAATAAAAACRACC  135
p16 T7-TGGAGTTTTYGGTTGATTGGTTGGTTA T3-CTACAAACCCTCTACCCACCTAAATC 144
RASSF2 T7-GTTTGTTTAGTTTGGTTGGATTTGAGTT T3-CTTACCTTCACCCCGAACCAACTACATC 150
CHFR T7-ATTAAGAGCGGTAGTTAAAGCGGAGT T3-TCCCTTCTACCCCAACATAACATAAC 156
Reprimo T7-TTTTGGGAAATTTTTACGGTTTAGGGATT3-TCGCTACTATTAACCAAAAACAAACCC 225
TPEF T7-TYGTGTTTTGTTGTTGTTGTTTTTTTGA
TATTTT 
T3- ATAAACTACCCGCACACTCATATACCAT
TC 
198
Y is the combination of C and T. 
R is the combination of G and A 
 
 
 
 
 
 
 
 
. 
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pairs of primers used in this work, where Y and R indicates that the primer contains either 
both C and T or both G and A at that given base. 
In the same way, SBE was carried out in a multiplex manner. In other words, all 
10 SBE reactions were performed in the same reaction tube. Prior to multiplex SBE, all 
of the SBE primers listed in table III were tested individually to check their performance 
and specificity. It is noted that the SBE primers were also designed to have both C and T 
or both G and A in the C position of the CpG sites in the case where there are CpG sites 
located within the sequences covered by the SBE primer sequences.  
4.4.3 Tag Sequence Selection 
Selection of highly discriminative sequences that can be used as the tags is 
critically important to SBE-TAGs microarray. During the course of this work, we found 
that many of the tag sequences reported in the literatures could still interact with each 
other, creating a high background that reduces the effectiveness of SBE-TAGs microarray. 
Hence, we first conducted a study to experimentally search for a set of good sequence 
tags. This is achieved by using a SBE method. Briefly, a synthesized oligo was used as 
the template for SBE. Each of the SBE primers consists of an identical sequence 
complementary to the sequence of the template and a unique sequence tag selected from 
70 candidate sequences (Favis et al. 2004). After the SBE reaction, all of the products 
with fluorescence labeling were hybridized on microarray slides with candidate 
sequences individually. We examined each of the 70 sequences to determine whether it 
has cross-hybridization with other sequences. With the selection criteria of signal/noise > 
10 folds, we were able to select 32 highly discriminative sequences from the 70 
sequences. 
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Table III. List of the Sequences of the SBE and Mini-Sequencing Primers. 
 
Primer Set Microarray SBE primer MALDI-TOF Mini-Sequencing primer  
MGMT TCRAAACRCAAAACRTTCTAAAAAC GCAAAACGTTCTAAAAAC 
GATA4 CCAAACRCRACCCCACCRAAACTACC GACCCCACCGAAACTACC 
HLTF CRCTACCTACTCTCCCCCTCTCC CCTACTCTCCCCCTCTCC 
p16_1 CACCTCCTCTACCCRACCCC CCTCCTCTACCCGACCCC 
p16_2 CCCCCRCCTCCAACAACRCCC CCGCCTCCAACAACGCCC 
SOCS1 AAAAAACAATTCCRCTAACRACTATC ATTCCGCTAACGACTATC 
RASSF2 ACTTCAACTACRCCTCRACCAAC AACTACGCCTCGACCAAC 
CHFR  CCTTCTACCCCAACATAACATAAC ACCCCAACATAACATAAC 
TPEF CCRCTCCAAAACRCCCCCTACC TCCAAAACGCCCCCTACC 
Reprimo CRAAAACTCCTCRCTCTACTTTC ACTCCTCGCTCTACTTTC 
R is the combination of G and A. 
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Fig. 11 Analysis of Control DNA 
with SBE-TAGs Microarray.
(A) Typical array spectra obtained 
from the samples containing 0%, 
10%, 30%, 50%, 70%, and 100% 
of methylated DNA. The green 
color shows the signal of Cy3 (the 
signal of the unmethylated allele) 
and the red color is the signal of 
Cy5 (the signal of the methylated 
allele). The intensity of the two 
channels reflects the difference in 
the degree of methylation; (B) 
The printing pattern of the 10 
probes spotted on microarray, in 
which three spots were printed for 
each probe and one probe detects 
methylation in one CpG site. 
Other than gene of p16 in which 
two CpG sites are targeted, only 
one CpG site is targeted in 8 other 
genes; (C) The standard 
calibration curves (plot of 
M/(M+U) vs. the percentage of 
methylated DNA) for all 10 
targeted CpG sites. 
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4.4.4 Analysis of Control DNA with SBE-TAGs Microarray  
We first studied the DNA samples containing control genomic DNA to generate 
criteria for determining the methylation status of each target CpG. Each CpG site in 
methylated control DNA is methylated, while each CpG site is unmethylated in 
unmethylated control DNA. The samples containing 0%, 10%, 30%, 50%, 70%, and 
100% of methylated DNA were used in this study, respectively, where the samples 
containing both methylated and unmethylated DNA were created by spiking methylated 
control genomic DNA into unmethylated control genomic DNA. 
The array spectra obtained from each sample were showed in Fig. 11A. Each 
array was printed with the fixed printing pattern shown in Fig. 11B and each probe was 
spotted on three positions to generate the average signal. It is seen that the Cy3 
(unmethylated) signal (the top panel spectra of Fig. 11A) decreased while the Cy5 
(methylated) signal (the bottom panel spectra of Fig. 11A) increases from left to right. 
This is consistent with the fact that the concentration of methylated DNA increased from 
left to right in the tested samples. It is also seen that the background signal still appears in 
the arrays even after we used highly discriminated tag probes. For example, the array 
spots for the CpG sites of p16_2, TPEF, and GATA4 yield the signal in the Cy5 channel 
when the sample containing no methylated DNA was used. The array spots corresponding 
to the CpG sites of CHFR, RASSF2, HLTF, and p16_2 yields the signal in the Cy3 
channel when the sample containing 100% of methylated DNA was used. One possible 
source for this background signal is cross-hybridization between the extension part of a 
SBE primer with the probes targeting other SBE reactions.   
Nevertheless, we found that the SBE-TAG microarray can still distinguish   
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methylated DNA from unmethylated DNA even in the presence of this background if we 
utilize the following quantitative approach. Briefly, the average signal of a methylated (M) 
allele or its unmethylated (U) allele of a target CpG site was first derived from three spots. 
The signals were then used to calculate the ratio of M/(M+U) or Cy5/(Cy5+Cy3), where 
the M/(M+U) ratio represents the methylation level or the percentage of the methylated 
allele in a CpG site. The ratio of M/(M+U) for each target CpG site was plotted vs. the 
percentage of methylated DNA to establish the standard calibration curves (Fig. 11C ). 
It was seen from Fig. 11C that for each target CpG site, there is a good linear 
relationship between M/(M+U) and the percentage of methylated DNA, and that 
M/(M+U) increased proportionally with the percentage of methylated DNA in the 
samples. We repeated this calibration at least four times and found that SBE-TAGS was 
robust and reproducible. This result shows that SBE-TAGs microarray in conjunction 
with the standard calibration approach can be used for multiplex methylation analysis. 
4.4.5 Analysis of Methylation of Cell Line DNA with SBE-TAGs Microarray  
Next, we utilize the calibration curves developed above to analyze the 
methylation status of DNA in two colorectal cancer cell lines of HCT116 and HTB38. 
HCT116 has been subjected to the comprehensive methylation analysis (Liang et al. 2000; 
Akiyama et al. 2003; Kondo et al. 2003; Akinoet al. 2005; Brandes et al. 2005; Mund et 
al. 2005; Takahashi et al. 2005; Takahashi et al. 2006), allowing us to examine the 
accuracy of the SBE-TAGs assay by comparing our result with the published data. 
HTB38 was rarely studied for its methylation and this work can yield insights into 
methylation of HTB38.  
Fig. 12 shows the results of four separate studies of HCT116 and HTB38. The  
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 Fig. 12 Using SBE-TAGs microarray for cell lines analysis. Array spectra obtained 
from analysis of cell lines of HCT116 (A) and HTB38 (B). Each cell line sample was 
independently studied four times.  
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signal of a probe in each array was averaged from 3 spots to determine the ratio of 
M/(M+U). The mean values of M/(M+U) were determined from four separate arrays and 
are listed in Table IV. It is seen that the SD (Standard Deviations) of the mean of 
M/(M+U) for all target CpG sites are between 2.4E-03 and 1.6E-05, establishing that the 
SBE-TAGs assay is reproducible. We also used the standard curves derived from Fig 11C 
to determine the methylation status of the 10 target CpG sites and found that in HCT116, 
8 of 9 genes and 9 of 10 CpG sites were methylated with the exception of RASSF2. This 
finding is in good agreement with the reported methylation level in HCT116. For 
example, published studies shown that RASSF2 is unmethylated while, other eight genes 
are methylated in HCT116 (Liang et al. 2000; Akiyama et al. 2003; Kondo et al. 2003; 
Akinoet al. 2005; Brandes et al. 2005; Mund et al. 2005; Takahashi et al. 2005; Takahashi 
et al. 2006). In HTB38, 8 of 9 genes (9 of 10 CpG sites) were found methylated, while 
MGMT was unmethylated. The main difference between HCT116 and HTB38 is that 
RASSF2 is unmethylated in HCT116, while MGMT is unmethylated in HTB38.  
4.4.6 Methylation Status Validation by MALDI-TOF based Mini-sequencing 
We also carried out a study of using MALDI-TOF based mini-sequencing (Sun 
et al. 2000) to determine the methylation status of the 10 target CpG sites in HCT116 and 
HTB38. MALDI-TOF can directly determine the molecular weight of mini-sequencing 
products without hybridization, eliminating any potential effects of cross-hybridization 
on methylation analysis. Hence, the MALDI-TOF based analysis can provide additional 
insights into the accuracy of SBE-TAGs microarray. Each mini-sequencing primer used is 
the same to the extension part of the corresponding SBE primer. In other words, 
mini-sequencing primers target the same CpG sites, but without the tag tail used in the  
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Table IV. Results of Analyzing 10 CpG Sites of 9 Genes in HCT116 and HTB38. 
 HCT116 HTB38 
 Mean of 
M/(M+U)
SD Mean of 
M/(M+U)
SD 
p16_1 0.788 9.80E-05 0.913 1.40E-04
RASSF2 0.123 1.60E-04 0.893 5.60E-05
HLTF 0.215 2.90E-04 0.775 2.60E-04
SOCS1 0.893 1.60E-04 0.587 9.20E-04
MGMT 0.334 1.20E-03 0.028 1.60E-05
CHFR 0.839 3.80E-04 0.45 1.90E-03
GATA4 0.943 1.30E-04 0.877 2.60E-04
p16_2 0.549 2.40E-03 0.919 3.60E-05
TPEF 0.935 8.60E-05 0.888 1.70E-04
Reprimo 0.303 1.50E-03 0.879 4.40E-04
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 Fig. 13 Typical MALDI-TOF spectra obtained from analysis of HCT116 and HTB38. 
Peak labeled by P, U, and M correspond to the primer peak, the peak extended from the 
unmethylated allele, and the peak extended from the methylated allele, respectively. (A) 
Analysis of HLTF in HCT116; (B) Analysis of HLTF in HTB38; (C) Analysis of MGMT 
in HCT116; (D) Analysis of MGMT in HTB38; (E) Analysis of RASSF2 in HCT116; (F) 
Analysis of RASSF2 in HTB38. 
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SBE primer. In addition, each CpG site was individually studied by MALDI-TOF. The 
result of MALDI-TOF based mini-sequencing was consistent with the result of 
SBE-TAGs. Several representative mass spectra obtained from MALDI-TOF were 
showed in Fig. 13. Figs. 13A and 13B shows the result of analyzing the targeted CpG site 
of HLTF in HCT116 and HTB38, respectively, where the M peak (methylated) was seen 
in both spectra, indicating that HLTF is methylated in both cell lines. Figs. 13C and 13D 
shows the results of analyzing the CpG site of MGMT in both HCT116 and HTB38, 
respectively, where only Fig. 13C has the observable M peak, indicating that MGMT is 
methylated in HCT116, but unmethylated in HTB38. Figs. 13E and 13F shows the results 
of analyzing the CpG site of RASSF2 in both HCT116 and HTB38, respectively, where 
only Fig. 4F has the observable M peak, indicating that MGMT is methylated in HTB38, 
but unmethylated in HCT116. Clearly, this MALDI-TOF mini-sequencing study further 
confirms that SBE-TAGs microarray is reliable and can accurately determine the 
methylation status of many genes in a multiplex manner. 
In conclusion, the SBE-TAGs microarray assay described in this report can 
accurately determine the methylation status of a number of CpG sites in a multiplexing 
manner. In addition, this SBE-TAGs microarray is robust and reproducible. Clearly, this 
work establishes that SBE-TAGs microarray is an effective method for multiplex 
methylation analysis.   
 
 79
CHAPTER V 
CHZMA: A NOVEL MICROARRAY METHOD FOR MULTIPLEX 
METHYLATION ANALYSIS OF TUMOR TISSUE SAMPLES 
5.1 Abstract 
Multiplex analysis of methylation in tumor tissue samples has been a challenge. 
This report describes a novel approach called Competing-Hybridization-Zipcode- 
MicroArray (CHZMA) for multiplex methylation analysis of tumor tissue samples, which 
is based on two steps of hybridization to achieve the specific detection of methylation on 
microarray. On the basis of analysis of seven genes (MGMT, GATA4, HLTF, SOCS1, 
RASSF2, ER, 3-OST-2), we found that the CHZMA assay can robustly detect 
methylation in the samples containing as low as 10% of methylated DNA. In addition, the 
CHZMA assay is validated with breast tumor tissues samples. This work suggests that 
CHZMA can be a new method in place of MSP for methylation analysis of tumor tissue 
samples.
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5.2 Introduction 
Because of the enormous potential of epigenetic markers in both cancer 
screening and treatment, considerable effort has been made to search for methylated 
genes that can be novel therapeutic targets or screening biomarkers (Mori et al. 2006; Liu 
et al. 2007; Schuebel et al. 2007). The commonly used approach to identify methylated 
genes in cancer consists of two steps. The first is to identify the genes that are 
underexpressed in cancer through gene expression of cell lines. The second step is to 
determine which genes among the candidate genes discovered in the first step are 
silenced by methylation and how they are associated with cancer. This is achieved by 
analysis of a number of non-tumor tissue and tumor tissue samples. 
Most of existing methods for methylation analysis are based on bisulfite 
treatment that converts cytosine to uracil whereas the methylated cytosine residues are 
unaltered. The treated DNA is then PCR amplified wherein Ts replace Us (former Cs), 
and Cs replace the methylated Cs. Thereafter, methylation analysis is performed using 
conventional genetic analysis methods. Although other methods are available (Toyota et 
al. 1999), the most commonly used methylation analysis method has been 
methylation-specific PCR (MSP) (Herman et al. 1996) or its real-time PCR variation 
(Eads et al. 2000) because of its high sensitivity and simplicity. However, the problem of 
MSP is its low throughput. In general, one MSP reaction reveals methylation of a gene at 
a time. This weakness has prevented one from performing large-scale methylation 
analysis.  
Microarray allows for parallel evaluation of the methylation status at numerous 
CpG sites within multiple genes of interest. The early application of microarray to 
 81
methylation analysis involved direct hybridization, utilizing oligonucleotide probes to 
target either the methylated or unmethylated alleles within target sequences (Gitan et al. 
2002). However, it is not sufficiently sensitive and robust for analysis of tissues 
containing low abundance of methylated DNA. Although additional work was done to 
improve direct hybridization by designing better probes (Kimura et al. 2005; Piotrowski 
et al. 2006), it is still not robust for methylation analysis. Ligation-based microarray 
methods were also developed for methylation analysis (Bibikova et al. 2006; Cheng et al. 
2006), but they are also not sufficiently robust for methylation analysis of tissue samples. 
This is due in part to the fact the specificity of annealing a ligation probe to a given 
sequence can vary greatly from one sequence to another (Bibikova et al. 2006, Dahl et al. 
2007). Furthermore, bisulfite treatment eliminates all Cs in unmethylated DNA and in 
non-CpG sites of methylated DNA and thus creates a nearly all C-less sequence of most 
3-base-DNA having predominantly A, G, and T. This reduction in sequences, relative to 
normal 4-base-DNA, makes hybridization less specific. 
In this report, we describe a novel method called CHZMA 
(Competing-Hybridization- Zipcode-MicroArray) for methylation analysis. Unlike other 
microarray methods, CHZMA utilizes two steps of hybridization to improve its 
specificity. Based on the principle of CHZMA, we have developed a multiplex assay to 
simultaneously survey methylation of seven genes in the presence of a 10 folds more 
excess of unmethylated DNA, indicating that CHZMA is sufficiently sensitive to detect 
methylated DNA in tumor tissue samples. 
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5.3 Materials and Methods 
5.3.1 Sample Collection and DNA Isolation 
Unmethylated control genomic DNA and methylated control genomic DNA 
were purchased from Millipore within CpGenomeTM DNA modification Kit (Millipore). 
Samples containing both methylated and unmethylated control DNA were created by 
spiking methylated control DNA into unmethylated control DNA. Tissue DNA was 
extracted from breast tissues samples using a QIAamp DNA mini kit (QIAGEN) 
according to the manufacture’s protocol. 
5.3.2 Sodium Bisulfite Treatment  
The CpGenomeTM DNA modification Kit (Millipore, Billerica, MA) was used 
for bisulfite treatment in this study. Bisufite treatment was performed using the protocol 
suggested by the manufacturer. The only exception was the desalting and desulfonation 
step. Briefly, after bisulfite treatment for 15 h at 50oC, a 50K Microcon centrifuge column 
(Millipore, Billerica, MA) was used in desalting, followed by washing the column 3 
times with 500μL ddH2O on Eppendorf Centrifuge 5415C (Eppendorf North America, 
Westbury, NY) at 9000RPM. In the desulfonation step, we transferred 500μL of 
0.1MNaOH solution to the column, and then spun it until the solution went through at 
3000RPM. The column was then washed twice with 500μL of ddH2O and 1 time TE 
buffer. Finally, the modified DNA was recovered from the column. The converted DNA 
was used immediately or stored at -20oC for further analysis. 
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5.3.3 Multiplex PCR 
The first PCR reaction contained 2μL of bisulfite-converted DNA, 300-400nM 
of each primer (Table V), 1× AmpliTaq Gold PCR buffer, 400 μM of each dNTP, 4 mM 
MgCl2, and 2.5U of AmpliTaq Gold polymerase (Applied Biosystems, Foster City, CA), 
respectively. The first run of PCR was performed at 95oC for 10min, then 42 cycles of 
95oC for 30 sec, 58oC for 45 sec, 72oC for 45 sec and a final extension at 72oC for 5 min 
on iCycler Thermal Cycler (Bio-Rad Laboratories, Hercules, CA). The second run PCR 
reaction contained 0.5μL of the template DNA produced from the first PCR, 400 nM of 
each universal primer (T3 AATTAACCCTCACTAAAGGG; T7 
GTAATACGACTCACTA TAGG), 1× AmpliTaq Gold PCR buffer, 400 μM of each dNTP, 
4 mM MgCl2, and 2.5 U of AmpliTaq Gold polymerase, respectively. The second PCR 
were carried out at 95oC for 10min, then 35 cycles of 95oC for 30 sec, 57oC for 30 sec, 
72oC for 30 sec and a final extension at 72oC for 5 min. 
5.3.4 Microarray Array Fabrication  
Microarray used was home-made. Briefly, synthetic oligonucleotides 
(MWG-Biotech, Piscataway, NJ) were dissolved in 3xSSC, 0.05% SDS, and 0.001% 
Chaps (Sigma-Aldrich, St. Louis, MO) spotting solution, as this buffer could improve 
immobilization of oligonucleotides on an aldehyde modified slide (CEL Associates, 
Pearland, TX). The oligonucleotides were spotted on the slides using XactII Compact 
Microarrayer (LabNEXT Inc., Glenview, IL). After printing, the slides were placed in a 
box at a 75%~100% relative humidity for 12~72 h. Then, the excess of aldehyde-reactive 
groups were deactivated by incubating the slides with Prontol Pre-Soak solution  
 84
Table V. PCR Primer Sequences. 
Primer 
Set 
Forward Primer Reverse Primer  Size 
(bp)
MGMT T7-TTTYGGATATGTTGGGATAGTT  T3-AAACRACCCAAACACTCACCAAATC 109
GATA4 T7-GGTTTGTTTTATTTTTAGGGCGGAGG T3-CATCCCGAACTACCCTACTAAATCCC 119
HLTF T7-GTTGGTTATTAGAGGGTGGGGCGGA T3-AACCGAAAACTCCATACTACTCCCC 124
SOCS1 T7-GAGTTYGTGGGTATTTTTTTGGTG  T3-ACTACCATCCAAATAAAAACRACC  135
RASSF2 T7-GTTTGTTTAGTTTGGTTGGATTTGAGTT T3-CTTACCTTCACCCCGAACCAACTACATC 150
ER  T7-GAGGTGTATTTGGATAGTAGTAAGTT T3-AAAAAAACCCCCCAAACCGTTAAAACC 174
3-OST-2 T7-TTTTGGTTAGTAGTTTTCGGAGAAGA T3-ATAAACCATAACTCCATAAACCCGC  168
ACTB T7-TGGTGATGGAGGAGGTTTAGTAAGT T3-AACCAATAAAACCTACTCCTCCCTTAA 133
 
Y is the combination of C and T. 
R is the combination of G and A. 
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(Corning, NY) for 25 min., followed by washing the slides with dH2O several times. 
5.3.5 Competing Hybridization 
A mixture of seven M probes (1μM of each), seven U probes (40-50μM of each), 
and an ACTB internal reference probe (1μM) was incubated with the PCR products for 
hybridization. Thehybridization was carried out on a PCR cycler by first denaturing DNA 
at 95 oC for 5min, followed by stepwise reducing the temperature at 0.1 oC/sec to 72 oC, 
then slowly reducing the temperature from 72 oC to 50 oC within 1.5h. Finally the 
hybridization temperature was maintained at 50 oC for 30min. The M probes and 
competing probes are listed in table VI. 
5.3.6 Probe Isolation  
6μL of streptavidin-coated magnetic beads (Dynabeads® M-280) were incubated 
with the above hybridization solution at the room temperature for one hour, allowing for 
bead capturing of the hybrids formed by the probes and PCR products. After washing, the 
beads were resuspended in 60μL of the microarray hybridization buffer, followed by 
heating the solution at 95 oC for 5min to release the captured probes. 
5.3.7 Microarray Hybridization and Data Analysis  
The captured probes were spotted on the ProPlate™ Multi-Array Slide System 
(Grace Bio-Labs, Inc.). The slide was incubated at 37 oC for 12h. After hybridization, the 
slide was rinsed one time each with 2×SSC, 1×SSC, 0.5×SSC, and ddH2O. Finally, the 
slide was spun dried immediately for 5 min at 200×g. The fluorescence signal emitted 
from an array slide was detected with a Typhoon 9410 (GE healthcare). The images 
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Table VI. Sequences of the Probes Used in Competing Hybridization. 
Probe Set Methylation-Specific Detection Probe Competing Probe 
MGMT Cy5-Zip-Code 1-AAAACCTACGAACGTCGAAA AAAACCTACAAACATCAAAA 
GATA4 Cy5-Zip-Code 2-CGCCCGAAACGCCTCCGAACGC CACCCAAAACACCTCCAAACAC 
HLTF Cy5-Zip-Code 3-CGCAACCGCCGAACGCACGC CACAACCACCAAACACACAC 
SOCS1 Cy5-Zip-Code 4-CACGCGAATACTCGTAAATCCC CACACAAATACTCATAAATCCC 
RASSF2 Cy5-Zip-Code 5-CGCCTCGACCAACGATCGACGA CACCTCAACCAACAATCAACAA 
ER Cy5-Zip-Code 6-GCGTTAACGACGACCGCGACG ACATTAACAACAACCACAACA 
3-OST-2 Cy5-Zip Code 7-ACGACCACGCGAATCGAACGTT ACAACCACACAAATCAAACATT 
ACTB Cy5-Zip-Code 8-ACCACCACCCAACACACAATAAC  
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acquired were then analyzed with Software ArrayVision 8.0 (GE healthcare). The signal 
intensity from each spot was corrected by subtracting the average background from the 
mean average intensity of that spot. The data generated from ArrayVision was exported in 
the Excel format for further analysis. The methylation status of a gene of interest was 
determined by the ratio of the signal of its corresponding M probe to the signal of the 
internal reference gene probe. 
5.3.8 Statistical Analysis 
The optimal cutoff values for the assignment of the methylation status were 
determined by the receiver-operator characteristic (ROC) curve analysis using MedCalc 
Software (Mariakerke, Belbium). This is achieved by maximizing both sensitivity and 
specificity (Enokida et al. 2005; Hoque et al.2006). 
5.3.9 MSP Analysis 
Each MSP reaction contained 1~10ng of bisulfite-converted DNA, 400 nM of 
each primer, 1×AmpliTaq Gold PCR buffer, 400 μM of each dNTP, 4 mM MgCl2, and 1.5 
units of AmpliTaq Gold polymerase (Applied Biosystems). PCR products were examined 
on 4% agarose gel. 
5.4 Results and Discussion 
5.4.1 Principle of CHZMA 
Fig. 14 displays the principle of CHZMA. In general, a CHZMA assay consists 
of five steps. Firstly, a DNA sample is subject to bisulfite treatment that converts cytosine 
to uracil whereas the methylated cytosine residues are resistant to this conversion.  
 88
 Fig. 14 Schematic representation of the principle of CHZMA. Two hypothetical CpG 
sites 1 and 2 are designed as methylated and unmethylated, respectively. After bisulfite 
conversion, the treated DNA is subject to PCR amplification using a gene-specific 3’ 
portion and an upstream universal sequence (highlighted in blue) in the first PCR. This 
universal sequence is used as a PCR primer to amplify all of target genes in the second 
PCR. all of the PCR products were labeled with biotin. In the competing hybridization, 
only methylated probe and internal reference probe with zip-code sequences were labeled 
with Cy5. To improve the hybridization specificity, excessive amount of the competing 
probes without zip-code and Cy5 modification were added in the competing system. 
After the following solid-phase extraction, only methylation probes and internal reference 
could hybridized on microarry slides for the signal detection. The relative methylated 
level could be present by the ratio of target gene and internal reference. 
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Secondly, the treated DNA is subject to multiplex PCR amplification by using a 
two-run PCR, in which all target sequences are first amplified by the first run of PCR. 
Each of the primers used in the first PCR has a target-specific part and a universal tail 
part. The target-specific part amplifies one of the target genes, while the tail part 
introduces a universal sequence for the second run of PCR. In this work, the T7 and T3 
sequences are used as the universal tail of the forward and reverse primers, respectively. 
Then, the products of the first PCR are further amplified using the T7 and T3 universal 
primers. A biotin tag is also added to the PCR products during the course of the second 
PCR.  
Thirdly, PCR products are incubated with a set of the methylation-specific 
detection probes (or M probe) and their respective competing probes (U probe). Each of 
the M probes has two parts: a methylation-specific sequence complementary to a 
methylated sequence of interest, and a zip-code tag complementary to a zip-code probe 
spotted on microarray. In addition, the M probes are labeled by a Cy5 dye. Each of the U 
probes only contains a sequence complementary to an unmethylated sequence. In this 
step, a competing hybridization scheme is utilized to improve the hybridization 
specificity, in which DNA fragments bind to either the M or U probes. The role that the U 
probes play herein is to inhibit non-specific hybridization between unmethylated 
sequences and the M probes. It was observed that the presence of a greatly more excess 
of the U probes could substantially improve the specificity  
of hybridization. As a result of this hybridization, the M probes can preferentially bind to 
the methylated DNA fragments. 
Fourthly, the hybrids formed in Step 3 are captured by solid-phase extraction 
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involving the use of streptavidin-coated magnetic bead, as each PCR product contains a 
biotin tag. The beads are washed, leading to removal of the un-reacted U and M probes. 
Then, the beads are heated to release the probes captured. The result of step 4 is to isolate 
the M probes that preferentially bind to the methylated DNA fragments. The quantity of 
an M probe captured can reflect the quantity of the methylated allele in a target sequence.    
Finally, the methylation status of each target sequence is analyzed using 
microarray. This is done by incubating the probes isolated in Steps 3 and 4 with 
microarray pre-spotted with a variety of zip-code probes. As mentioned above, the second 
part of an M probe is a zip-code tag that is complementary to a zip-code probe spotted on 
microarray. Each zip-code tag has a unique sequence containing all four nucleotides of A, 
G, T, C, minimizing cross-hybridization. It is noted that the U probes do not contain the 
zip-code tag, thus not being captured and detected by microarray. Similar to quantitative 
MSP (Harden et al. 2003), CHZMA also utilizes an unmethylated gene, ACTB, as 
internal reference to measure the methylation status of a gene. In other words, the 
methylation status of a gene is determined on the basis of the signal ratio of its 
corresponding M probe to the zip-code probe for detecting ACTB.   
5.4.2 Specificity and Sensitivity of CHZMA  
We first studied the specificity and sensitivity of CHZMA using the samples 
created by spiking methylated control DNA into unmethylated control DNA. The 
methylated status at each CpG site is known in control DNA. Seven genes were selected 
for this study and they were MGMT, GATA4, HLTF, SOCS1, RASSF2, ER, 3-OST-2, 
respectively. Only one methylation-specific detection probe was used to determine the 
methylation status of one target gene. The samples containing 0%, 3%, 5%, 10%, 50%,  
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and 100% of methylated DNA were studied, respectively. We found that the specificity of 
hybridization involved in Step 3 was poor in the absence ofthe U probes, but the presence 
of an excessive amount of the U probes greatly improved the specificity. Fig. 15A shows 
the result when the same quantity of the M and U probes were used, while Fig. 15B 
shows the result when a 40-folds more excess of the U probes were present. It was seen 
that the presence of a 40-50 folds more excess of the U probes led to the best 
discrimination. Hence, a 40 fold more excess of the U probes were used in the remaining 
of this study. 
Experimentally, we first determine the background signal (Rb), i.e. the signal 
ratio of a M probe to the internal reference gene probe when no methylated DNA is 
present. Then, we measured the same signal ratio (R) in the samples containing 3%, 5%, 
10%, 25%, and 50% of methylated DNA, respectively. Table VII lists the result of the 
statistical analysis of the CHZMA assay when it was used to analyze the samples 
containing 0% or 10% of methylated DNA, respectively. Each of the samples was 
analyzed 25 times. Then, we determined the average signal ratios of R and Rb for each 
gene. It was seen that in each case, the R value determined for the samples containing 
10% of mehtylated DNA is about 3 times or more larger than Rb. Statistical analysis also 
suggests that the difference between R and Rb is statistically significant with the p value 
of less than 1.9X10-5 in all seven genes, suggesting that CHMZA is still robust to detect 
all methylated genes if the samples contain only 10% of methylated DNA. It was noted 
that in some cases, CHZMA could detect as little as 3% of methylated DNA. 
Receiver operating characteristics (ROC) curve (plotting sensitivity vs. 
100-specificity) is a useful method to evaluate the performance of a diagnostic test in  
 92
 Fig. 15 Effect of amounts of the U probes on the specificity of hybridization. (A) The 
molar quantity of an M probe used in hybridization is the same to that of its 
corresponding U probe; (B) a 40 folds more excess of the U probe than the M probe was 
used in hybridization; (C) The fixed printing pattern of 8 zip-code probes spotted on a 
assay slide. Seven probes are used to detect seven genes (one for each gene) and the 
eighth probe is for the detection of the internal reference gene, ATCB. 
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Table VII. Statistical Analysis of the Performance of CHZMA. 
100% Specificity 100% Sensitivity   
Rb
 
R 
 
P-value Cutoff 
Valuea
Sensitivity
% 
Cutoff 
Valueb
Specificity 
% 
MGMT 0.248 0.631 1.5X10-13 0.382 88 0.364 88 
GATA4 0.141 0.716 7.8X10-10 0.249 96 0.226 88 
HLTF 0.253 1.775 2.0X10-15 0.526 100 0.526 100 
SOCS1 0.070 0.370 1.1X10-07 0.144 100 0.144 100 
RASSF2 0.075 0.425 1.9X10-05 0.142 92 0.123 96 
ER 0.082 0.295 3.1X10-23 0.121 100 0.121 100 
3-OST-2 0.490 1.886 1.7X10-20 0.856 100 0.856 100 
 
Cutoff Valuea is determined at 100% specificity. 
Cutoff Valueb is determined at 100% sensitivity. 
Rb is the ratio of unmethylated control DNA, and R is the ratio of 10% methylated 
control DNA. 
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 Fig. 16 ROC curve. Representative receiver-operator characteristic (ROC) curves for 
analysis of MGMT (left) and GATA4 (right).  
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Hoque et al. 2006), in which the sensitivity and specificity of an assay can be determined 
on the basis of the cutoff value. Fig. 16 shows the representative ROC curves for analysis 
of MGMT and GATA4, respectively. The curves were obtained for the samples 
containing 10% of methylated DNA. 
In this study, the optimum cutoff values, maximizing the sum of sensitivity and 
specificity, were derived. Sensitivity is defined as the percentage of the samples that are 
correctly identified as methylated in the samples containing the same abundance of 
methylated DNA. Specificity is defined as the percentage of the samples that are 
correctly called as unmethylated in the samples containing only unmehtylated DNA. 
Table 3 lists the cutoff values when the samples contain 10% of methylated DNA at 
100% of sensitivity and 100% of specificity, respectively. As seen from Table 3, with a 
specificity of 100%, CHZMA has a sensitivity of 88% (MGMT), 92% (RASSF2), 96% 
(GATA4), and 100% (HLTF, SOCS1, ER, and 3-OST-2), respectively. With a sensitivity 
of 100%, CHZMA has a specificity of 88% (MGMT), 96% (RASSF2), 88% (GATA4), 
and 100% (HLTF, SOCS1, ER, and 3-OST-2), respectively.  
5.4.3 Analysis of Breast Cancer Tissues 
The CHZMA assay developed in this work can robustly reveal methylation in 
the samples containing as little as 10% of methylation DNA, allowing for methylation 
analysis of tumor tissues. Hence, we next apply this assay to analysis of 5 normal breast 
tissues and 11 breast cancer tissues. The DNA extracted from the tissue samples was 
subject the CHZMA analysis in the same manner as outlined above. Briefly, after the 
microarray data analysis, the methylation status of each gene in each sample was 
classified using the cutoff values (100% of specificity) listed in Table 3. In other words,  
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Table VIII. Methylated Primer Sets for Methylation-Specific PCR. 
Primer set Forward Primer Reverse Primer Size 
(bp) 
Anneal 
Temperature
MGMT CGTTTCGACGTTCGTAGGTTTTCGC AACCACTCGAAACTACCACCGTCC 121 60℃ 
GATA4 GGTTTTGCGTTCGGAGGCGTTTC ATAAACGACTCCGTCGACTCCCG 120 66℃ 
HLTF GATCGCGTGCGTTCGGCGGTT GACCCCGAACCGCGACCGTAA 132 64℃ 
SOCS1 CGCGTGTATTTTTAGGTCGGTCGT GCGAAACTCTTCCCGACGAATAAA 117 59.5℃ 
RASSF2 TTCGTCGATCGTTGGTCGAGGC CGCGCCTTACCTTCACCCCGA 124 64℃ 
ER TCGCGGTCGTCGTTAACGCGTA AACGAACTCGAAAACACGCTATTAAAT 133 60℃ 
3-OST-2 TAACGTTCGATTCGCGTGGTCGT AACTCCATAAACCCGCGCCGAAA 124 60℃ 
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for a given gene, this gene is called methylated if its measured R value is larger than the 
corresponding cutoff value, otherwise this gene is called unmethylated. Fig. 17A displays 
the result of analyzing the 16 tissue samples. The red color indicates that the measure R 
value for a given gene is larger than its correposning cutoff value, thus reveal that this 
gene is methylated in a sample of interest. The green color indicates that a gene is 
unmethylated in a tissue sample of interest. 90.9% (10 of 11) of cancer samples were 
found methylated in at least one target gene, while only one normal tissue of S5 was 
methylated in ER, 3-OST-2, and GATA4. It has reported that aging can also cause 
methyaiton in ER, 3-OST-2, and GATA4 (Issa et al. 1997; Takahashi et al. 2006). Hence, 
it is not totally surprised to observe methylated ER in a normal breast tissue. 
To validate the result of CHAZM, we also used MSP to determine the 
methylation status of the same seven genes in two tissue samples of S8 and S9, in which, 
one of the two primers used in a MSP reaction was designed to target the same sequence 
covered by an M probe, allowing for the direct comparison of MSN with CHZMA. In 
addition, only MSP reactions for detecting methylated DNA were performed and ach 
gene was individually studied by MSP. The MSP result was shown in Fig. 17B. It is seen 
that the MSP result is concordant with the methylaiton status determined by CHAMZ, 
except for the case of 3-OST-2 in the sample of S9, where MSP revealed that 3-OST-2 
was methylation, while 3-OST-2 was called unmethylated by CHZMA. This discrepancy 
may be due to the difference in the detection sensitivity. MSP is highly sensitive and can 
detect one methylated allele in 1,000 copies of unmethylated alleles (Eads et al. 2000), 
while CHZMA is robust to detect 10% or higher abundance of methylated DNA. During 
the course of this work, we found that the methylation level can vary greatly from gene to  
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 Fig. 17 Methylation analysis of tissue samples. (A) The result of analysis of 5 normal 
breast tissues (S1-S5) and 11 breast cancer tissues (S6-S16) with the CHZMA assay, in 
which the measured R value for each target gene in a given tissue samples is listed. The 
red color indicates that the measure R value for a gene is larger than the its correposning 
cutoff values, while the green color indicates that the R value for a gene is smaller than 
the corresponding cutoff value. (B) MSP analysis of Samples S8 and S9. A clear band 
suggests that the corresponding gene is methylated in tissue. Otherwise the gene is 
unmethylated.    
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gene even in the tissue sample. The abundance of the methylated gene of 3-OST-2 may 
simply be lower than 10% in Sample of S9 and thus cannot be detected by CHZMA.  
Clearly, this study demonstrates that CHZMA is a reliable method for 
methylation analysis, which can robustly detect as low as 10% of methylated DNA. In 
principle, the number of target sequences that can be simultaneously amplified by PCR 
limits the throughput of a CHZMA assay. During the course of this study, we found that 
the PCR strategy used in this work can simultaneously amplify more than 10 different 
sequences. Therefore, one CHZMA assay should be able to detect methylation in at least 
10 genes and this throughput is 10 folds higher than that of MSP. Considering the fact 
that CHZMA is sufficiently sensitive to detect 10% of methylated DNA, we believe that 
CHZMA can be a good high-throughput method in place of MSP for methylation analysis 
of tumor tissue samples.  
Recently, a novel random whole-genome amplification method called BiMP was 
developed to amplify bisulfite-treated DNA (Reinders et al. 2008). Unlike the standard 
whole-genome method, BiMP reduces the length of the random primers from 6mers to 
4mers to favor the priming of smaller DNA fragments. As a result, improved uniformity 
of amplification of whole-genome was achieved. A combination of BiMP with CHZMA 
may eventually offer a technology that allows for genome-wide, high-resolution DNA 
methylation profiling using bisulfite-treated DNA.  
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APPENDIX 
The sequences of 32 Zip-Code 
1 TGGGTCCACAGTACCGCTGCAGA 
2 CCGTGGGAGATTAGGTGGCTCAGA 
3 GGGAATGGAGGTGGGAACGAGACA 
4 CGCAAAGCAGACACAGGGTCGATT 
5 GGGAGGCTGCTGTCCTTTCGATCA 
6 AGACGCACCGCAACAGGCTGTCAA 
7 TTGCAACGGGCTGGTCAACGTCAA 
8 GCACCGATATGGAGACCGCAGACA 
9 GGCTCGCAGGCTGGCTCATCCTAA 
10 GGCTGCACCCGTTGAGGCACATCA 
11 GTCCGTCCATGGCAAGCGTGATCA 
12 ACAGCGTGTTCGTTGCTTGCATCA 
13 CATCGCTGCAAGTACCGCACTCAA 
14 GCACGGGAGCTGACGACGTGTCAA 
15 CAAGGCACGTCCCAGACGCATCAA 
16 CGCAGGTCGCTGCGTGTCCTGATT 
17 GTCCCAAGTTGCGGCTCACTTTCG 
18 AACGGGGAAGGTTGAGCGTGACAG 
19 ATGGCGATGGTCCACTCGCAATCA 
20 TTCGCCGTCGTGTAGGCTTTTCAA 
21 CATCCAAGGTCCGACACGCAACGA 
22 CGCATTCGATGGACAGGACATTCG 
23 AAGCAAGCCAAGGTATGGCTTTGC 
24 ACGAGGGATACCCGCAAACGATCA 
25 CGTGGCTGACTCGCTGCGATGACA 
26 CGCAATGGTAGGTGAGCAAGCAGA 
27 ATGGCCGTGCTGGGGACAAGTCAA 
28 GCTGGCTGGCACGCACCAGAATCA 
29 CACTGCACACGAAACGGCACACAG 
30 CGTGCGCACACTCACTGTCCTTCG 
31 TTCGGCTGTTCGTAGGCAAGAGGT 
32 GGCTGGGACGTGCAGACCGTTCAA 
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